<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?properties manuscript?><front><journal-meta><journal-id journal-id-type="nlm-journal-id">101256108</journal-id><journal-id journal-id-type="pubmed-jr-id">32579</journal-id><journal-id journal-id-type="nlm-ta">Int J Obes (Lond)</journal-id><journal-id journal-id-type="iso-abbrev">Int J Obes (Lond)</journal-id><journal-title-group><journal-title>International journal of obesity (2005)</journal-title></journal-title-group><issn pub-type="ppub">0307-0565</issn><issn pub-type="epub">1476-5497</issn></journal-meta><article-meta><article-id pub-id-type="pmid">23628854</article-id><article-id pub-id-type="pmc">3750057</article-id><article-id pub-id-type="doi">10.1038/ijo.2013.54</article-id><article-id pub-id-type="manuscript">NIHMS460254</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title><italic>FTO</italic> predicts weight regain in the Look AHEAD Clinical Trial</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>McCaffery</surname><given-names>Jeanne</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Papandonatos</surname><given-names>George D.</given-names></name><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Huggins</surname><given-names>Gordon S.</given-names></name><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author"><name><surname>Peter</surname><given-names>Inga</given-names></name><xref ref-type="aff" rid="A4">4</xref></contrib><contrib contrib-type="author"><name><surname>Kahn</surname><given-names>Steven E.</given-names></name><xref ref-type="aff" rid="A5">5</xref></contrib><contrib contrib-type="author"><name><surname>Knowler</surname><given-names>William C.</given-names></name><xref ref-type="aff" rid="A6">6</xref></contrib><contrib contrib-type="author"><name><surname>Hudnall</surname><given-names>Gina Evans</given-names></name><xref ref-type="aff" rid="A7">7</xref></contrib><contrib contrib-type="author"><name><surname>Lipkin</surname><given-names>Edward</given-names></name><xref ref-type="aff" rid="A8">8</xref></contrib><contrib contrib-type="author"><name><surname>Kitabchi</surname><given-names>Abbas E.</given-names></name><xref ref-type="aff" rid="A9">9</xref></contrib><contrib contrib-type="author"><name><surname>Wagenknecht</surname><given-names>Lynne E.</given-names></name><xref ref-type="aff" rid="A10">10</xref></contrib><contrib contrib-type="author"><name><surname>Wing</surname><given-names>Rena R.</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><collab>The Genetic Subgroup of Look AHEAD and The Look AHEAD Research Group</collab></contrib></contrib-group><aff id="A1"><label>1</label>Weight Control and Diabetes Research Center, Department of Psychiatry and Human Behavior, The Miriam Hospital and Brown Medical School, Providence, RI</aff><aff id="A2"><label>2</label>Center of Statistical Sciences, Brown University, Providence, R.I.</aff><aff id="A3"><label>3</label>MCRI Center for Translational Genomics, Molecular Cardiology Research Institute, Tufts Medical Center, Boston, MA</aff><aff id="A4"><label>4</label>Department of Genetics and Genomic Sciences, Mount Sinai School of Medicine, New York, NY</aff><aff id="A5"><label>5</label>Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, VA Puget Sound Health Care System and University of Washington, Seattle, WA</aff><aff id="A6"><label>6</label>National Institute of Diabetes and Digestive and Kidney Diseases, Phoenix, AZ</aff><aff id="A7"><label>7</label>Baylor College of Medicine &#x00026; Michael E. DeBakey VA Medical Center, Houston, TX</aff><aff id="A8"><label>8</label>Division of Endocrinology, Diabetes &#x00026; Metabolism, University of Tennessee Health Science Center, Memphis, TN</aff><aff id="A9"><label>9</label>Department of Medicine, Division of Metabolism, Endocrinology and Nutrition, University of Washington, Seattle, WA</aff><aff id="A10"><label>10</label>Division of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC</aff><author-notes><corresp id="cor1">Corresponding Author: <bold>Jeanne McCaffery, PhD</bold>, Associate Professor, Weight Control and Diabetes Research Center, The Miriam Hospital and Brown Medical School, 196 Richmond Street, Providence, R.I. 02903, Phone: 401 793-8101, Fax: 401 793-8944, <email>jeanne_mccaffery@brown.edu</email></corresp></author-notes><pub-date pub-type="nihms-submitted"><day>9</day><month>4</month><year>2013</year></pub-date><pub-date pub-type="epub"><day>03</day><month>4</month><year>2013</year></pub-date><pub-date pub-type="ppub"><month>12</month><year>2013</year></pub-date><pub-date pub-type="pmc-release"><day>01</day><month>6</month><year>2014</year></pub-date><volume>37</volume><issue>12</issue><fpage>1545</fpage><lpage>1552</lpage><!--elocation-id from pubmed: 10.1038/ijo.2013.54--><permissions><license><license-p>Users may view, print, copy, download and text and data- mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:
<uri xlink:type="simple" xlink:href="http://www.nature.com/authors/editorial_policies/license.html#terms">http://www.nature.com/authors/editorial_policies/license.html#terms</uri></license-p></license></permissions><abstract><sec id="S1"><title>Background</title><p id="P1">Genome-wide association studies have provided new insights into the genetic factors that contribute to the development of obesity. We hypothesized that these genetic markers would also predict magnitude of weight loss and weight regain after initial weight loss.</p></sec><sec id="S2"><title>Methods</title><p id="P2">Established obesity risk alleles available on the <italic>Illumina CARe iSelect</italic> (IBC) chip were characterized in 3,899 overweight or obese participants with type 2 diabetes from the Look AHEAD (Action for Health in Diabetes), a randomized trial to determine the effects of intensive lifestyle intervention (ILI) and Diabetes Support and Education (DSE) on cardiovascular morbidity and mortality. Primary analyses examined the interaction between 13 obesity-risk polymorphisms in 8 genes and randomized treatment arm in predicting weight change at year 1, and weight regain at year 4 among individuals who lost 3% or more of their baseline weight by year 1.</p></sec><sec id="S3"><title>Results</title><p id="P3">No SNPs were significantly associated with magnitude of weight loss or interacted with treatment arm at year 1. However, <italic>FTO</italic> rs3751812 predicted weight regain within DSE (1.56 kg per risk allele, p = 0.005), but not ILI (p = 0.761), resulting in SNP&#x000d7;treatment arm interaction (p = 0.009). In a partial replication of prior research, the obesity risk (G) allele at <italic>BDNF</italic> rs6265 was associated with greater weight regain across treatment arms (0.773 kg per risk allele), although results were of borderline statistical significance (p=0.051).</p></sec><sec id="S4"><title>Conclusions</title><p id="P4">Variations in the <italic>FTO</italic> and <italic>BDNF</italic> loci may contribute risk of weight regain after weight loss.</p></sec></abstract><kwd-group><kwd>type 2 diabetes</kwd><kwd>obesity</kwd><kwd>weight loss, diet, genetics</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="S5"><title>Introduction</title><p id="P5">Obesity is a major public health problem associated with increased risk of a number of diseases, including cardiovascular disease (CVD), type 2 diabetes and certain cancers. Behavioral weight loss is the treatment of choice for mild to moderate obesity<xref rid="R1" ref-type="bibr">1</xref> as weight losses of 10% have repeatedly been documented to improve diabetes<xref rid="R2" ref-type="bibr">2</xref> and cardiovascular disease risk factors<xref rid="R3" ref-type="bibr">3</xref>,<xref rid="R4" ref-type="bibr">4</xref>. At the same time, the long-term maintenance of these losses remains a critical issue in obesity treatment.</p><p id="P6">Obesity susceptibility loci identified through genome-wide association studies (GWAS) and replicated in multiple independent cohorts have provided new insights into the genetic factors that contribute to the development of obesity. The fat mass and obesity associated gene (<italic>FTO</italic>) was one of the first genes to be identified by this approach and it has emerged as an important gene associated with obesity and body mass in numerous cohorts <xref rid="R5" ref-type="bibr">5</xref>&#x02013;<xref rid="R7" ref-type="bibr">7</xref>. With increasing samples sizes in GWAS studies, the number of confirmed loci continues to increase <xref rid="R5" ref-type="bibr">5</xref>&#x02013;<xref rid="R7" ref-type="bibr">7</xref>.</p><p id="P7">The treatment implications of these obesity susceptibility loci remain unclear. In particular, it is not known whether obesity-risk genetic markers predict success with weight loss or weight loss maintenance. Previously, in the Diabetes Prevention Program, <italic>FTO</italic> rs9939609 predicted a greater increase in subcutaneous adipose tissue in the placebo group compared to lifestyle intervention at year 1, but no significant genotype&#x000d7;treatment interaction was observed for overall weight loss<xref rid="R8" ref-type="bibr">8</xref>. The obesity risk allele at rs6265 in <italic>BDNF</italic> was also associated with greater weight regain at two year follow-up among those who lost 3% or more of their initial weight at six-months<xref rid="R9" ref-type="bibr">9</xref>.</p><p id="P8">The goal of the present study was to define the effects of obesity genetic risk markers available on the <italic>Illumina CARe iSelect</italic> IBC chip<xref rid="R10" ref-type="bibr">10</xref> (within or in the region of <italic>FTO, SH2B1, MC4R, BDNF, TNNI3K, MTIF3, QPCTL/GIPR, and TFAP2B)</italic> on weight loss at 1 year in response to gold standard behavioral weight loss intervention, and weight regain from year 1 to 4 among those who lost 3% or more of their initial weight at year 1. The Look AHEAD trial, a randomized controlled trial designed to determine the effects of intensive lifestyle intervention, including diet and physical activity, on cardiovascular morbidity and mortality among overweight individuals with type 2 diabetes, provides a unique opportunity to conduct such analyses.</p></sec><sec sec-type="materials|methods" id="S6"><title>Material and Methods</title><sec id="S7"><title>Study cohort</title><p id="P9">The Look AHEAD study enrolled 5,145 ethnically diverse overweight and obese subjects with type 2 diabetes and aged 45 to 76 years. Of these, 1,038 did not provide genetic consent to be included in a genetic ancillary study, including all participants from three Southwest American Indian sites, 10 withdrew consent for genotyping and 60 were identified to have no or a low concentration of DNA. This left 4,037 individuals, of which 3,899 contributed genetic data on at least one of the 13 markers of interest that passed genotyping quality control procedures. These subjects form the basis for the present analyses. Overall, relative to those who provided genetic consent, those who did not were more frequently African-American, Hispanic, female, more highly educated and not dyslipidemic. Consent rates did not differ by BMI<xref rid="R11" ref-type="bibr">11</xref>.</p><p id="P10">The design and methods of the Look AHEAD trial have been reported elsewhere, as have the baseline characteristics of the randomized cohort<xref rid="R12" ref-type="bibr">12</xref>. Briefly, at baseline participants were randomized to either an Intensive Lifestyle Intervention (ILI) or a Diabetes Support and Education (DSE) arm. Both the ILI and DSE groups were provided one session of education on diabetes and cardiovascular risk factors. In addition, ILI patients received an intensive lifestyle program, combining diet modification and increased physical activity, designed to produce an average of 7% weight loss and maintain these weight losses. The ILI included one individual and three group meetings per month for six months, followed by one individual and two group meetings per month through one year. From years 2&#x02013;4, participants were seen individually at least once a month, contacted another time each month by telephone or email, and offered a variety of ancillary classes. These sessions focused on behavioral weight loss strategies, such as self-monitoring, goal setting and stimulus control, to achieve and maintain weight loss. The DSE group received the option of attending three sessions per year on nutrition, physical activity and social support with no explicit weight loss goals. In the full trial<xref rid="R3" ref-type="bibr">3</xref>,<xref rid="R4" ref-type="bibr">4</xref>, maximal difference in average weight loss across intervention arm occurred at 1 year follow-up (8.6% in ILI vs. 0.7% in DSE, p &#x0003c; 0.001), with an average weight loss of 4.7% in ILI and 1.1% in DSE at year 4 follow-up.</p><p id="P11">The Look AHEAD trial was approved by local Institutional Review Boards, including genetic analyses.</p></sec><sec id="S8"><title>Anthropometric Measures</title><p id="P12">Weight was measured in duplicate at baseline and year 1 and 4 follow-ups using a digital scale and height was measured at baseline and year 4 using a standard wall-mounted stadiometer. Weight regain was defined as weight change from year 1 &#x02013; year 4 among individuals initially losing at least some weight (&#x0003e;=3%) at year 1 following methods used in the Diabetes Prevention Program<xref rid="R9" ref-type="bibr">9</xref>. As can be seen in <xref ref-type="table" rid="T1">Table 1a</xref>, among those who lost 3% or more weight at year 1, women regained 3.7&#x000b1;8.2 and men regained 4.8&#x000b1;7.8 from year 1 &#x02013; 4 on average. It is important to note, however, that only 72.5% of women and 78.5% of men in this subgroup regained weight, as defined by a weight at year 4 greater than their weight at year 1, while the remaining individuals either maintained or continued to lose weight.</p></sec><sec id="S9"><title>Genotyping</title><p id="P13">The genomic DNA extraction was based on the use of FlexiGene DNA Kit (Qiagen Inc., Valencia, CA) as described by the manufacturer and DNA quantitation was performed using the PicoGreen dsDNA Quantitation Reagent (Invitrogen, Inc., Carlsbad, CA). Genotyping was carried out at the Children&#x02019;s Hospital of Philadelphia using the <italic>Illumina CARe iSelect</italic> (IBC) chip, a gene-centric 50,000 single nucleotide polymorphism (SNP) array designed to assess relevant loci across a range of cardiovascular, metabolic and inflammatory syndromes <xref rid="R10" ref-type="bibr">10</xref>. Taqman Applied Biosystems (ABI) Assays-On-Demand were used to genotype the <italic>MC4R</italic> polymorphism rs17782313 (ABI catalogue number C_32667060_10)) using an Applied Biosystems 7900HT.</p></sec><sec id="S10"><title>Gene and SNP Selection</title><p id="P14">We performed a search of published literature and selected SNPs that had been associated with obesity by GWAS <xref rid="R5" ref-type="bibr">5</xref>&#x02013;<xref rid="R7" ref-type="bibr">7</xref>,<xref rid="R13" ref-type="bibr">13</xref>&#x02013;<xref rid="R19" ref-type="bibr">19</xref> and appeared on the IBC chip <xref rid="R10" ref-type="bibr">10</xref> or, in the case of <italic>MC4R</italic> rs17782313, had been genotyped by Taqman. References for the selection of each SNP are provided in <xref ref-type="table" rid="T2">Table 2</xref>. As multiple markers have showed the strongest association with obesity in the <italic>FTO</italic> region<xref rid="R6" ref-type="bibr">6</xref>,<xref rid="R13" ref-type="bibr">13</xref>,<xref rid="R16" ref-type="bibr">16</xref>,<xref rid="R18" ref-type="bibr">18</xref> and two distinct loci have been identified in the <italic>BDNF</italic> region<xref rid="R6" ref-type="bibr">6</xref>, we retained multiple SNPs in each of these regions. <italic>FTO</italic> rs1421085, rs3751812 and rs9939609, <italic>BDNF</italic> rs6265 and rs10767664 and <italic>TFAP2B</italic> rs2272903 were assayed directly on the IBC chip. GWAS obesity SNPs not on the IBC chip were replaced by proxies where possible using the SNP Annotation and Proxy Search tool (SNAP) <xref rid="R20" ref-type="bibr">20</xref> based on haplotype maps of individuals of European ancestry (CEU) and Yoruba people of Ibadan (YRI) as follows: <italic>FTO</italic> rs9930506 was replaced by rs9922708 (distance 681 bp r2=1.00, D&#x02019;=1.00 in both CEU and YRI); <italic>BDNF</italic> rs925946 was replaced by rs1401635 (distance 26,789 bp r2=0.96, D&#x02019;=1.00 in CEU; no proxy was available in YRI), <italic>SH2B1</italic> rs7498665 was replaced by rs4788099 (distance 27,514 bp r2=1.00, D&#x02019;=1.00 in CEU and D&#x02019;=1.00 and r2=0.94 in YRI), <italic>TNNI3K</italic> rs1514175 was replaced by rs1514176 (distance 48 bp, r2=1.00, D&#x02019;=1.00 in CEU and r2=1.00, D&#x02019;=1.00 in YRI), <italic>MTIF3</italic> rs4771122 was replaced by rs7988412 (distance 19898, r2=0.83, D&#x02019;=1.00 in CEU; no proxy was available in YRI), and <italic>QPCTL/GIPR</italic> rs2287019 was replaced by rs11672660 (distance 21988 bp, r2=0.83, D&#x02019;=1.00 in CEU, r2=0.89, D&#x02019;=1.00 in YRI).</p><p id="P15">The four <italic>FTO</italic> SNPs selected for inclusion were in strong linkage disequilibrium in non-Hispanic Whites (r<sup>2</sup>=0.78&#x02013;0.97), but differed in the degree of disequilibrium among African-Americans (rs3751812, rs1421085: r2=0.98; rs3751812, rs9922708: r2=0.70; rs1421085, rs9922708: r2=0.67; rs9939609 with other SNPs: r2&#x0003c;0.36). In contrast, two <italic>BDNF</italic> SNPs, rs6265 and rs10767664, were in strong linkage disequilibrium in both non-Hispanic Whites (r2=0.88) and African-Americans (r2=0.81).</p><p id="P16">Observed genotype frequencies were compared with those expected under Hardy Weinberg Equilibrium (HWE) using stratified &#x003a7;<sup>2</sup> tests within the two largest racial/ethnic groups (non-Hispanic White and African-American). All SNPs under study conformed to HWE (p &#x0003e; 0.001).</p></sec><sec id="S11"><title>Statistical Analysis</title><p id="P17">To control for admixed study population, all IBC SNPs were examined by principal component analysis (PCA) using the EIGENSTRAT algorithm <xref rid="R21" ref-type="bibr">21</xref> as implemented in Golden Helix version 7.1 (Bozeman, Montana, USA). PCA results indicated that the majority of the variance among the Look AHEAD cohort was accounted for by the first two principal components, which agreed with self-reported ethnicity (<xref ref-type="supplementary-material" rid="SD1">Supplemental Figure 1</xref>). Accordingly, the first two principal components were included as covariates in our analyses to adjust for population stratification in the multi-ethnic Look AHEAD cohort.</p><p id="P18">As the primary adiposity outcome in the Look AHEAD clinical trial is weight (not body mass index), we focus on baseline weight (in kg) and change in weight (in kg) as primary outcomes. Longitudinal linear mixed models were used to model the effect of SNP on weight change by treatment arm over time. As baseline weight as well as treatment response can be associated with the SNPs, baseline was modeled as the first time point in longitudinal analyses as recommended by McArdle &#x00026; Whitcomb, 2009<xref rid="R22" ref-type="bibr">22</xref>. Within this model, differential SNP effects on year 1 weight change or by treatment arm are detected through SNP (0,1 or 2 copies of the minor allele) &#x000d7; time (baseline, year 1) &#x000d7; treatment arm (ILI, DSE) interaction. An additive genetic model was used for all markers, with genotype coded by the number of minor alleles. Therefore, all our SNP effects can be interpreted as the effect on the outcome of interest of one additional copy of the corresponding minor allele. Models were estimated in Splus 8.2 <xref rid="R23" ref-type="bibr">23</xref> using restricted maximum likelihood. Longitudinal outcomes were additionally adjusted for age, gender, study site, and the first two ancestry informative marker principal components.</p><p id="P19">Next, we examined the extent to which the genetic markers predicted weight regain at year 4. As weight regain implies initial weight loss, we limited analyses to those who lost 3% or more of their initial weight at year 1, consistent with prior analyses focusing on weight regain in the Diabetes Prevention Program<xref rid="R9" ref-type="bibr">9</xref>. Interest centered on whether SNP effects, if present, could be averaged across treatment arms or should be presented in a treatment-specific fashion (SNP &#x000d7; treatment arm interaction). The same covariates were employed as above, with the addition of year 1 weight.</p><p id="P20">To adjust for multiple comparisons, we calculated the effective number of independent genetic loci using principal component analysis as recommended by Li and Ji<xref rid="R24" ref-type="bibr">24</xref>. Principal component analysis of the genotypic correlation matrix of the 13 markers of interest identified 10 independent loci in the full and non-Hispanic White samples. Therefore, one can maintain the family-wise error rate at 0.05 via Sidak&#x02019;s adjustment for multiplicity by declaring as significant only those markers with a nominal significance level of 0.05/10=0.005. However, as the markers were selected <italic>a priori</italic>, we also discuss results with p values less than 0.05 not adjusted for multiple testing. All analyses were performed at Brown University.</p></sec></sec><sec sec-type="results" id="S12"><title>Results</title><sec id="S13"><title>Descriptive statistics</title><p id="P21">Participant characteristics of the sub-cohort of Look AHEAD used in these analyses are shown in <xref ref-type="table" rid="T1">Table 1</xref>. Individuals were evenly distributed between the ILI and DSE intervention arms, and had comparable age, gender and ethnicity as in the entire cohort (data not shown). No baseline differences in demographic or clinical characteristics across ILI and DSE were observed. Similar to the larger Look AHEAD trial<xref rid="R3" ref-type="bibr">3</xref>, participants assigned to ILI lost significantly more weight at year 1 and 4 than those assigned to DSE. SNP characteristics, including the obesity risk allele identified in the prior literature, are presented in <xref ref-type="table" rid="T2">Table 2</xref>.</p></sec><sec id="S14"><title>Genetic associations with baseline weight</title><p id="P22">Genetic associations of SNP markers with baseline weight are listed in <xref ref-type="table" rid="T3">Table 3</xref>. Obesity risk alleles in <italic>FTO</italic>, <italic>SH2B1</italic> and <italic>QPCTL/GIPR</italic> regions predicted baseline weight in directions consistent with prior research. Risk alleles for the markers in these 3 genes were associated with elevated baseline weight of 1.01&#x02013;1.29 kg per copy. Similar associations were found for baseline BMI (<xref ref-type="table" rid="T3">Table 3</xref>), with BMI effects per risk allele in the 0.38&#x02013;0.46 range.</p></sec><sec id="S15"><title>Genetic associations with weight loss at year 1</title><p id="P23">Genetic associations of the full set of SNP markers with year 1 weight change in ILI and DSE are listed in <xref ref-type="supplementary-material" rid="SD1">Supplemental Table 1</xref>. No SNPs were significantly associated with the magnitude of weight change in either ILI or DSE or interacted with treatment arm in predicting the degree of weight change</p></sec><sec id="S16"><title>Weight regain</title><p id="P24">Participant characteristics for those who lost 3% or more at year 1 of their weight at baseline are presented in <xref ref-type="table" rid="T1">Table 1a</xref>. Genetic associations of the full set of SNP markers with weight at year 4 in this subgroup is presented in <xref ref-type="table" rid="T4">Table 4</xref>. The obesity risk (A) allele at <italic>FTO</italic> rs3751812 was significantly associated with weight regain in DSE (1.559 kg per risk allele, p = 0.005), but not ILI (-0.092 kg per risk allele, p = 0.761), resulting in SNP&#x000d7;treatment arm interaction (p = 0.009). Similar effects were seen for <italic>FTO</italic> rs1421085 and rs9922708.</p><p id="P25">A regional plot of the association of <italic>FTO</italic> with differential change in weight regain across ILI and DSE is depicted in <xref ref-type="supplementary-material" rid="SD1">Supplemental Figure 2</xref>. Of interest, rs3751812 and SNPs in linkage disequilibrium do not show the strongest association with differential weight change across ILI and DSE. One SNP, rs8061397, in a distinct linkage disequilibrium block is associated with differential change in weight across ILI and DSE (p = 6.4 &#x000d7;10&#x02212;5), suggesting a possible additional signal in the region.</p><p id="P26">In a possible replication of prior research, the obesity risk (G) allele at <italic>BDNF</italic> rs6265 was associated with greater weight regain across treatment arms (0.773 kg per risk allele), although results were of borderline statistical significance (p=0.051). When combined, the <italic>FTO</italic> and <italic>BDNF</italic> SNPs accounted for R<sup>2</sup> = 1.43% of year 4 weight across treatment arms.</p></sec></sec><sec sec-type="discussion" id="S17"><title>Discussion</title><p id="P27">This paper presents the results of the largest study to date examining whether SNPs previously associated with obesity predict weight loss in response to behavioral treatment or weight regain after successful weight loss treatment. We found no significant SNP associations with magnitude of weight loss at year 1 or SNP &#x000d7; treatment arm interactions in predicting year 1 weight change, suggesting behavioral factors, such as adherence to weight loss recommendations, may predominate in predicting initial weight loss. However, the obesity risk region within <italic>FTO</italic> was significantly associated with weight regain in the control group, but not in the lifestyle intervention group, resulting in SNP &#x000d7; treatment arm interaction. Further, variation within <italic>BDNF</italic> was associated with weight regain across treatment arms in replication of prior results in the Diabetes Prevention Program<xref rid="R9" ref-type="bibr">9</xref>. Overall, these results suggest that the obesity risk alleles do not appear to be strongly predictive of the magnitude of weight loss in response to behavioral intervention but may instead be associated with weight regain after weight loss.</p><p id="P28"><italic>FTO</italic> was the first gene to show replicated association with obesity in GWAS<xref rid="R13" ref-type="bibr">13</xref>,<xref rid="R16" ref-type="bibr">16</xref>,<xref rid="R18" ref-type="bibr">18</xref>,<xref rid="R25" ref-type="bibr">25</xref> and continues to show the strongest association with obesity and body mass index across a variety of populations<xref rid="R5" ref-type="bibr">5</xref>. This region also shows strong evidence for gene&#x000d7;behavior interaction as the interaction of obesity-risk alleles at <italic>FTO</italic> with physical activity in predicting body weight has been confirmed by replication and meta-analysis in epidemiologic studies<xref rid="R26" ref-type="bibr">26</xref>. In the context of randomized, controlled trials, <italic>FTO</italic> rs9939609 predicted a greater increase in subcutaneous adipose tissue in the placebo group compared to lifestyle intervention at year 1, but no significant genotype &#x000d7; treatment interaction was observed for overall weight loss in the Diabetes Prevention Program<xref rid="R8" ref-type="bibr">8</xref>. In the POUNDS LOST trial<xref rid="R27" ref-type="bibr">27</xref>, the minor allele at <italic>FTO</italic> rs1558902 predicted greater free fatty mass in response to a low-protein diet but less free fatty mass in response to a high fat diet at two year follow-up, again with no effect on weight change. The present results extend this gene &#x000d7; behavior interaction to the context of a combined caloric restriction and physical activity intervention arm in a longitudinal randomized, controlled clinical trial with four year follow-up. Taken together, these results indicate that behavioral strategies may blunt <italic>FTO</italic> effects on weight gain and weight regain after weight loss. However, the detection of effects of the <italic>FTO</italic> region on weight loss may require detailed measurements of body fat, such as with dual energy X-ray absorptiometry scan.</p><p id="P29">Previously in the DPP, the obesity risk allele at rs6265 in <italic>BDNF</italic> was associated with greater weight regain over 2 years among those who had initially lost 3% at or more at six months. The effect occurred across all three treatment arms: a lifestyle intervention promoting weight loss and physical activity, 850 mg metformin twice daily, and placebo<xref rid="R9" ref-type="bibr">9</xref>. In Look AHEAD, we provide some evidence, albeit of marginal significance (p = 0.051), for association of the obesity risk allele at rs6265 with weight regain at four-year follow-up among those who had lost 3% at one-year follow-up across two treatment arms. <italic>BDNF</italic> and its primary receptor TrkB are widely expressed in the brain, including key regions of the hypothalamus and dorsal vagal complex related to body weight and energy homeostasis<xref rid="R28" ref-type="bibr">28</xref>,<xref rid="R29" ref-type="bibr">29</xref>. In these regions, infusion of <italic>BDNF</italic> produces appetite suppression and weight loss<xref rid="R30" ref-type="bibr">30</xref>,<xref rid="R31" ref-type="bibr">31</xref>. Conversely, targeted disruption of <italic>BDNF</italic> in transgenic models results in hyperphagia and obesity <xref rid="R32" ref-type="bibr">32</xref>&#x02013;<xref rid="R36" ref-type="bibr">36</xref>. In a prior Look AHEAD study, <italic>BDNF</italic> rs6265 was associated with greater total caloric intake and more servings from the dairy and the meat, eggs, nuts and beans food groups<xref rid="R37" ref-type="bibr">37</xref>. At least one case study also links rare mutations in <italic>BDNF</italic> to severe obesity in an 8-year-old girl<xref rid="R38" ref-type="bibr">38</xref>.</p><p id="P30">This study has several strengths, including a randomized clinical trial design, a highly effective behavioral weight loss intervention and inclusion of multiple genetic markers previously associated with obesity. The sample size of the study is both a strength and limitation. While this is the largest study to examine genetic predictors of weight loss and weight maintenance, it is smaller in size than samples used to discover the obesity risk SNPs under consideration. It is plausible that the inclusion of more obesity risk polymorphisms would have identified additional associations with weight loss or regain. However, we did include markers reflecting several of the strongest associations with obesity, including those within <italic>FTO, MC4R</italic> and <italic>BDNF</italic>. Although we sought to define the role of obesity risk SNPs in weight loss and weight regain, it is possible that genetic factors associated with weight loss and regain may derive from different pathways than those influencing obesity per se. An agnostic approach, such as GWAS or exome sequencing, may be required to identify such pathways. Finally, this cohort was selected for type 2 diabetes and overweight and the generalization of these results to other populations remains to be determined.</p><p id="P31">Overall, our findings advance existing knowledge on the treatment implications of obesity susceptibility loci derived from GWAS. No significant SNP associations with magnitude of weight loss at year 1 or SNP&#x000d7;treatment arm interactions in predicting year 1 weight change were observed. However, we identify <italic>FTO</italic> and <italic>BDNF</italic> as possible predictors of weight regain after weight loss.</p></sec><sec sec-type="supplementary-material" id="SM"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SD1"><label>1</label><media xlink:href="NIHMS460254-supplement-1.docx" mimetype="application" mime-subtype="octet-stream" orientation="portrait" xlink:type="simple" id="d37e706" position="anchor"/></supplementary-material></sec></body><back><ack id="S18"><title>Acknowledgement</title><p id="P32">We acknowledge the Look AHEAD sites that participated in this ancillary study.</p><p id="P33"><underline>Johns Hopkins Medical Institutions</underline> Frederick L. Brancati, MD, MHS<xref ref-type="other" rid="P66">1</xref>; Jeff Honas, MS<xref ref-type="other" rid="P67">2</xref>; Lawrence Cheskin, MD<xref ref-type="other" rid="P68">3</xref>; Jeanne M. Clark, MD, MPH<xref ref-type="other" rid="P68">3</xref>; Kerry Stewart, EdD<xref ref-type="other" rid="P68">3</xref>; Richard Rubin, PhD<xref ref-type="other" rid="P68">3</xref>; Jeanne Charleston, RN; Kathy Horak, RD</p><p id="P34"><underline>Pennington Biomedical Research Center</underline> George A. Bray, MD<xref ref-type="other" rid="P66">1</xref>; Kristi Rau<xref ref-type="other" rid="P67">2</xref>; Allison Strate, RN<xref ref-type="other" rid="P67">2</xref>; Brandi Armand, LPN<xref ref-type="other" rid="P67">2</xref>; Frank L. Greenway, MD<xref ref-type="other" rid="P68">3</xref>; Donna H. Ryan, MD<xref ref-type="other" rid="P68">3</xref>; Donald Williamson, PhD<xref ref-type="other" rid="P68">3</xref>; Amy Bachand; Michelle Begnaud; Betsy Berhard; Elizabeth Caderette; Barbara Cerniauskas; David Creel; Diane Crow; Helen Guay; Nancy Kora; Kelly LaFleur; Kim Landry; Missy Lingle; Jennifer Perault; Mandy Shipp, RD; Marisa Smith; Elizabeth Tucker</p><p id="P35"><underline>University of Alabama at Birmingham</underline> Cora E. Lewis, MD, MSPH<xref ref-type="other" rid="P66">1</xref>; Sheikilya Thomas MPH<xref ref-type="other" rid="P67">2</xref>; Monika Safford, MD<xref ref-type="other" rid="P68">3</xref>; Vicki DiLillo, PhD; Charlotte Bragg, MS, RD, LD; Amy Dobelstein; Stacey Gilbert, MPH; Stephen Glasser, MD; Sara Hannum, MA; Anne Hubbell, MS; Jennifer Jones, MA; DeLavallade Lee; Ruth Luketic, MA, MBA, MPH; Karen Marshall; L. Christie Oden; Janet Raines, MS;</p><p id="P36">Cathy Roche, RN, BSN; Janet Truman; Nita Webb, MA; Audrey Wrenn, MAEd</p><p id="P37"><underline>Harvard Center</underline></p><p id="P38"><italic>Massachusetts General Hospital</italic>: David M. Nathan, MD<xref ref-type="other" rid="P66">1</xref>; Heather Turgeon, RN, BS, CDE<xref ref-type="other" rid="P67">2</xref>; Kristina Schumann, BA<xref ref-type="other" rid="P67">2</xref>; Enrico Cagliero, MD<xref ref-type="other" rid="P68">3</xref>; Linda Delahanty, MS, RD<xref ref-type="other" rid="P68">3</xref>; Kathryn Hayward, MD<xref ref-type="other" rid="P68">3</xref>; Ellen Anderson, MS, RD<xref ref-type="other" rid="P68">3</xref>; Laurie Bissett, MS, RD; Richard Ginsburg, PhD; Valerie Goldman, MS, RD; Virginia Harlan, MSW; Charles McKitrick, RN, BSN, CDE; Alan McNamara, BS; Theresa Michel, DPT, DSc CCS; Alexi Poulos, BA; Barbara Steiner, EdM; Joclyn Tosch, BA</p><p id="P39"><italic>Joslin Diabetes Center</italic>: Edward S. Horton, MD<xref ref-type="other" rid="P66">1</xref>; Sharon D. Jackson, MS, RD, CDE<xref ref-type="other" rid="P67">2</xref>; Osama Hamdy, MD, PhD<xref ref-type="other" rid="P68">3</xref>; A. Enrique Caballero, MD<xref ref-type="other" rid="P68">3</xref>; Sarah Bain, BS; Elizabeth Bovaird, BSN, RN; Ann Goebel-Fabbri, PhD; Lori Lambert, MS, RD; Sarah Ledbury, MEd, RD; Maureen Malloy, BS; Kerry Ovalle, MS, RCEP, CDE</p><p id="P40"><italic>Beth Israel Deaconess Medical Center</italic>: George Blackburn, MD, PhD<xref ref-type="other" rid="P66">1</xref>; Christos Mantzoros, MD, DSc<xref ref-type="other" rid="P68">3</xref>; Kristinia Day, RD; Ann McNamara, RN</p><p id="P41"><underline>University of Colorado Health Sciences Center</underline> James O. Hill, PhD<xref ref-type="other" rid="P66">1</xref>; Marsha Miller, MS, RD<xref ref-type="other" rid="P67">2</xref>; JoAnn Phillipp, MS<xref ref-type="other" rid="P67">2</xref>; Robert Schwartz, MD<xref ref-type="other" rid="P68">3</xref>; Brent Van Dorsten, PhD<xref ref-type="other" rid="P68">3</xref>; Judith Regensteiner, PhD<xref ref-type="other" rid="P68">3</xref>; Salma Benchekroun MS; Ligia Coelho, BS;</p><p id="P42">Paulette Cohrs, RN, BSN; Elizabeth Daeninck, MS, RD; Amy Fields, MPH; Susan Green; April Hamilton, BS, CCRC; Jere Hamilton, BA; Eugene Leshchinskiy; Michael McDermott, MD; Lindsey Munkwitz, BS; Loretta Rome, TRS; Kristin Wallace, MPH; Terra Worley, BA</p><p id="P43"><underline>Baylor College of Medicine</underline> John P. Foreyt, PhD<xref ref-type="other" rid="P66">1</xref>; Rebecca S. Reeves, DrPH, RD<xref ref-type="other" rid="P67">2</xref>; Henry Pownall, PhD<xref ref-type="other" rid="P68">3</xref>; Ashok Balasubramanyam, MBBS<xref ref-type="other" rid="P68">3</xref>; Peter Jones, MD<xref ref-type="other" rid="P68">3</xref>; Michele Burrington, RD; Chu-Huang Chen, MD, PhD; Allyson Clark, RD; Molly Gee, MEd, RD; Sharon Griggs; Michelle Hamilton; Veronica Holley; Jayne Joseph, RD; Patricia Pace, RD: Julieta Palencia, RN; Olga Satterwhite, RD;</p><p id="P44">Jennifer Schmidt; Devin Volding, LMSW; Carolyn White</p><p id="P45"><underline>University of Tennessee Health Science Center</underline></p><p id="P46"><italic>University of Tennessee East.</italic> Karen C. Johnson, MD, MPH; Carolyn Gresham, RN; Stephanie Connelly, MD, MPH; Amy Brewer, RD, MS; Mace Coday, PhD; Lisa Jones, RN; Lynne Lichtermann, RN, BSN; Shirley Vosburg, RD, MPH; and J. Lee Taylor, MEd, MBA</p><p id="P47"><italic>University of Tennessee Downtown.</italic> Abbas E. Kitabchi, PhD, MD; Helen Lambeth, RN, BSN; Debra Clark, LPN; Andrea Crisler, MT; Gracie Cunningham; Donna Green, RN; Debra Force, MS, RD, LDN; Robert Kores, PhD; Renate Rosenthal PhD; Elizabeth Smith, MS, RD, LDN; and Maria Sun, MS, RD, LDN; and Judith Soberman, MD<xref ref-type="other" rid="P68">3</xref></p><p id="P48"><underline>University of Minnesota Robert</underline> W. Jeffery, PhD<xref ref-type="other" rid="P66">1</xref>; Carolyn Thorson, CCRP<xref ref-type="other" rid="P67">2</xref>; John P. Bantle, MD<xref ref-type="other" rid="P68">3</xref>; J. Bruce Redmon, MD<xref ref-type="other" rid="P68">3</xref>; Richard S. Crow, MD<xref ref-type="other" rid="P68">3</xref>; Scott Crow, MD<xref ref-type="other" rid="P68">3</xref>; Susan K Raatz, PhD, RD<xref ref-type="other" rid="P68">3</xref>; Kerrin Brelje, MPH, RD; Carolyne Campbell;</p><p id="P49">Jeanne Carls, MEd; Tara Carmean-Mihm, BA; Emily Finch, MA; Anna Fox, MA; Elizabeth Hoelscher, MPH, RD, CHES; La Donna James; Vicki A. Maddy, BS, RD; Therese Ockenden, RN; Birgitta I. Rice, MS, RPh CHES; Tricia Skarphol, BS; Ann D. Tucker, BA; Mary Susan Voeller, BA; Cara Walcheck, BS, RD</p><p id="P50"><underline>St. Luke&#x02019;s Roosevelt Hospital Center</underline> Xavier Pi-Sunyer, MD<xref ref-type="other" rid="P66">1</xref>; Jennifer Patricio, MS<xref ref-type="other" rid="P67">2</xref>; Stanley Heshka, PhD<xref ref-type="other" rid="P68">3</xref>; Carmen Pal, MD<xref ref-type="other" rid="P68">3</xref>; Lynn Allen, MD; Diane Hirsch, RNC, MS, CDE; Mary Anne Holowaty, MS, CN</p><p id="P51"><underline>University of Pennsylvania</underline> Thomas A. Wadden, PhD<xref ref-type="other" rid="P66">1</xref>; Barbara J. Maschak-Carey, MSN, CDE<xref ref-type="other" rid="P67">2</xref>; Stanley Schwartz, MD<xref ref-type="other" rid="P68">3</xref>; Gary D. Foster, PhD<xref ref-type="other" rid="P68">3</xref>; Robert I. Berkowitz, MD<xref ref-type="other" rid="P68">3</xref>; Henry Glick, PhD<xref ref-type="other" rid="P68">3</xref>; Shiriki K. Kumanyika, PhD, RD, MPH<xref ref-type="other" rid="P68">3</xref>; Johanna Brock; Helen Chomentowski; Vicki Clark; Canice Crerand, PhD; Renee Davenport; Andrea Diamond, MS, RD; Anthony Fabricatore, PhD; Louise Hesson, MSN; Stephanie Krauthamer-Ewing, MPH; Robert Kuehnel, PhD; Patricia Lipschutz, MSN; Monica Mullen, MS, RD; Leslie Womble, PhD, MS; Nayyar Iqbal, MD</p><p id="P52"><underline>University of Pittsburgh</underline> David E. Kelley, MD<xref ref-type="other" rid="P66">1</xref>; Jacqueline Wesche-Thobaben, RN, BSN, CDE<xref ref-type="other" rid="P67">2</xref>; Lewis Kuller, MD, DrPH<xref ref-type="other" rid="P68">3</xref>; Andrea Kriska, PhD<xref ref-type="other" rid="P68">3</xref>; Janet Bonk, RN, MPH; Rebecca Danchenko, BS; Daniel Edmundowicz, MD<xref ref-type="other" rid="P68">3</xref>; Mary L. Klem, PhD, MLIS<xref ref-type="other" rid="P68">3</xref>; Monica E. Yamamoto, DrPH, RD, FADA <xref ref-type="other" rid="P68">3</xref>; Barb Elnyczky, MA; George A. Grove, MS; Pat Harper, MS, RD, LDN; Janet Krulia, RN, BSN, CDE; Juliet Mancino, MS, RD, CDE, LDN; Anne Mathews, MS, RD, LDN; Tracey Y. Murray, BS; Joan R. Ritchea; Jennifer Rush, MPH; Karen Vujevich, RN-BC, MSN, CRNP; Donna Wolf, MS</p><p id="P53"><underline>Miriam Hospital/Brown Medical School</underline> Rena R. Wing, PhD<xref ref-type="other" rid="P66">1</xref>; Renee Bright, MS<xref ref-type="other" rid="P67">2</xref>; Vincent Pera, MD<xref ref-type="other" rid="P68">3</xref>; John Jakicic, PhD<xref ref-type="other" rid="P68">3</xref>; Deborah Tate, PhD<xref ref-type="other" rid="P68">3</xref>; Amy Gorin, PhD<xref ref-type="other" rid="P68">3</xref>; Kara Gallagher, PhD<xref ref-type="other" rid="P68">3</xref>; Amy Bach, PhD; Barbara Bancroft, RN, MS; Anna Bertorelli, MBA, RD; Richard Carey, BS; Tatum Charron, BS; Heather Chenot, MS; Kimberley Chula-Maguire, MS; Pamela Coward, MS, RD; Lisa Cronkite, BS; Julie Currin, MD; Maureen Daly, RN; Caitlin Egan, MS; Erica Ferguson, BS, RD; Linda Foss, MPH; Jennifer Gauvin, BS; Don Kieffer, PhD; Lauren Lessard, BS; Deborah Maier, MS; JP Massaro, BS; Tammy Monk, MS; Rob Nicholson, PhD; Erin Patterson, BS; Suzanne Phelan, PhD; Hollie Raynor, PhD, RD; Douglas Raynor, PhD; Natalie Robinson, MS, RD; Deborah Robles; Jane Tavares, BS</p><p id="P54"><underline>University of Texas Health Science Center at San Antonio</underline> Steven M. Haffner, MD<xref ref-type="other" rid="P66">1</xref>; Maria G. Montez, RN, MSHP, CDE<xref ref-type="other" rid="P67">2</xref>; Carlos Lorenzo, MD<xref ref-type="other" rid="P68">3</xref></p><p id="P55"><underline>University of Washington / VA Puget Sound Health Care System</underline> Steven Kahn MB, ChB<xref ref-type="other" rid="P66">1</xref>; Brenda Montgomery, RN, MS, CDE<xref ref-type="other" rid="P67">2</xref>; Robert Knopp, MD<xref ref-type="other" rid="P68">3</xref>; Edward Lipkin, MD<xref ref-type="other" rid="P68">3</xref>; Matthew L. Maciejewski, PhD<xref ref-type="other" rid="P68">3</xref>; Dace Trence, MD<xref ref-type="other" rid="P68">3</xref>; Terry Barrett, BS; Joli Bartell, BA; Diane Greenberg, PhD; Anne Murillo, BS; Betty Ann Richmond, MEd; April Thomas, MPH, RD</p><p id="P56"><underline>Coordinating Center, Wake Forest University</underline> Mark A. Espeland, PhD<xref ref-type="other" rid="P66">1</xref>; Judy L. Bahnson, BA<xref ref-type="other" rid="P67">2</xref>; Lynne Wagenknecht, DrPH<xref ref-type="other" rid="P68">3</xref>; David Reboussin, PhD<xref ref-type="other" rid="P68">3</xref>; W. Jack Rejeski, PhD<xref ref-type="other" rid="P68">3</xref>; Alain Bertoni, MD, MPH<xref ref-type="other" rid="P68">3</xref>; Wei Lang, PhD<xref ref-type="other" rid="P68">3</xref>; Gary Miller, PhD<xref ref-type="other" rid="P68">3</xref>; David Lefkowitz, MD<xref ref-type="other" rid="P68">3</xref>; Patrick S. Reynolds, MD<xref ref-type="other" rid="P68">3</xref>; Paul Ribisl, PhD<xref ref-type="other" rid="P68">3</xref>; Mara Vitolins, DrPH<xref ref-type="other" rid="P68">3</xref>; Michael Booth, MBA<xref ref-type="other" rid="P67">2</xref>; Kathy M. Dotson, BA<xref ref-type="other" rid="P67">2</xref>; Amelia Hodges, BS<xref ref-type="other" rid="P67">2</xref>; Carrie C. Williams, BS<xref ref-type="other" rid="P67">2</xref>; Jerry M. Barnes, MA; Patricia A. Feeney, MS; Jason Griffin, BS; Lea Harvin, BS; William Herman, MD, MPH; Patricia Hogan, MS; Sarah Jaramillo, MS; Mark King, BS; Kathy Lane, BS; Rebecca Neiberg, MS; Andrea Ruggiero, MS; Christian Speas, BS; Michael P. Walkup, MS; Karen Wall, AAS; Michelle Ward; Delia S. West, PhD; Terri Windham</p><p id="P57"><underline>Central Laboratory, Northwest Lipid Research Laboratories</underline> Santica M. Marcovina, PhD, ScD<xref ref-type="other" rid="P66">1</xref>; Greg Strylewicz, MS</p><p id="P58"><underline><bold>Federal Sponsors</bold></underline></p><p id="P59"><underline>National Institute of Diabetes and Digestive and Kidney Diseases</underline>: Barbara Harrison, MS; Van S. Hubbard, MD PhD; Susan Z.Yanovski, MD</p><p id="P60"><underline>National Heart, Lung, and Blood Institute</underline>: Lawton S. Cooper, MD, MPH; Jeffrey Cutler, MD, MPH; Eva Obarzanek, PhD, MPH, RD</p><p id="P61"><underline>Centers for Disease Control and Prevention</underline>: Edward W. Gregg, PhD; David F. Williamson, PhD; Ping Zhang, PhD</p><p id="P62"><underline><bold>Funding and Support</bold></underline></p><p id="P63">This study is supported by the Department of Health and Human Services through the following cooperative agreements from the National Institutes of Health: DK57136, DK57149, DK56990, DK57177, DK57171, DK57151, DK57182, DK57131, DK57002, DK57078, DK57154, DK57178, DK57219, DK57008, DK57135, and DK56992. The following federal agencies have contributed support: National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; National Institute of Nursing Research; National Center on Minority Health and Health Disparities; Office of Research on Women&#x02019;s Health; and the Centers for Disease Control and Prevention.</p><p id="P64">Additional support was received from The Johns Hopkins Medical Institutions Bayview General Clinical Research Center (M01RR02719); the Massachusetts General Hospital Mallinckrodt General Clinical Research Center (M01RR01066); the University of Colorado Health Sciences Center General Clinical Research Center (M01RR00051) and Clinical Nutrition Research Unit (P30 DK48520); the University of Tennessee at Memphis General Clinical Research Center (M01RR0021140); the University of Pittsburgh General Clinical Research Center (M01RR00005644) and NIH grants (DK 046204 and DK072497); and VA Puget Sound Health Care System and Department of Veterans Affairs; Frederic C. Bartter General Clinical Research Center (M01RR01346). AKH was supported by the Training Program in Cardiovascular Research (NIH, 5T32HL069770)</p><p id="P65">The following organizations have committed to make major contributions to Look AHEAD: Federal Express; Health Management Resources; Johnson &#x00026; Johnson, LifeScan Inc.; Optifast-Novartis Nutrition; Roche Pharmaceuticals; Ross Product Division of Abbott Laboratories; Slim-Fast Foods Company; and Unilever.</p><p id="P66"><sup>1</sup> Principal Investigator</p><p id="P67"><sup>2</sup> Program Coordinator</p><p id="P68"><sup>3</sup> Co-Investigator</p><p id="P69">All other Look AHEAD staffs are listed alphabetically by site.</p></ack><fn-group><fn id="FN1" fn-type="conflict"><p id="P70"><bold>Disclosure</bold></p><p id="P71">The authors have no conflict of interest to declare.</p></fn><fn id="FN2"><p id="P72">Supplementary information is available at IJO's website' at the end of the article and before the references.</p></fn></fn-group><ref-list><title>References</title><ref id="R1"><label>1</label><element-citation publication-type="journal"><source>Centers for Medicare and Medicaid Services: Decision Memo for Intensive Behavioral Therapy for Obesity (CAG-00423N)</source><year>2011</year></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knowler</surname><given-names>WC</given-names></name><name><surname>Barrett-Connor</surname><given-names>E</given-names></name><name><surname>Fowler</surname><given-names>SE</given-names></name><name><surname>Hamman</surname><given-names>RF</given-names></name><name><surname>Lachin</surname><given-names>JM</given-names></name><name><surname>Walker</surname><given-names>EA</given-names></name><etal/></person-group><article-title>Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin</article-title><source>N Engl J Med</source><year>2002</year><volume>346</volume><fpage>393</fpage><lpage>403</lpage><pub-id pub-id-type="pmid">11832527</pub-id></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pi-Sunyer</surname><given-names>X</given-names></name><name><surname>Blackburn</surname><given-names>G</given-names></name><name><surname>Brancati</surname><given-names>FL</given-names></name><name><surname>Bray</surname><given-names>GA</given-names></name><name><surname>Bright</surname><given-names>R</given-names></name><name><surname>Clark</surname><given-names>JM</given-names></name><etal/></person-group><article-title>Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial</article-title><source>Diabetes Care</source><year>2007</year><volume>30</volume><fpage>1374</fpage><lpage>1383</lpage><pub-id pub-id-type="pmid">17363746</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wing</surname><given-names>RR</given-names></name></person-group><article-title>Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial</article-title><source>Archives of internal medicine</source><year>2010</year><volume>170</volume><fpage>1566</fpage><lpage>1575</lpage><pub-id pub-id-type="pmid">20876408</pub-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Speliotes</surname><given-names>EK</given-names></name><name><surname>Willer</surname><given-names>CJ</given-names></name><name><surname>Berndt</surname><given-names>SI</given-names></name><name><surname>Monda</surname><given-names>KL</given-names></name><name><surname>Thorleifsson</surname><given-names>G</given-names></name><name><surname>Jackson</surname><given-names>AU</given-names></name><etal/></person-group><article-title>Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index</article-title><source>Nat Genet</source><year>2010</year><volume>42</volume><fpage>937</fpage><lpage>948</lpage><pub-id pub-id-type="pmid">20935630</pub-id></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thorleifsson</surname><given-names>G</given-names></name><name><surname>Walters</surname><given-names>GB</given-names></name><name><surname>Gudbjartsson</surname><given-names>DF</given-names></name><name><surname>Steinthorsdottir</surname><given-names>V</given-names></name><name><surname>Sulem</surname><given-names>P</given-names></name><name><surname>Helgadottir</surname><given-names>A</given-names></name><etal/></person-group><article-title>Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity</article-title><source>Nat Genet</source><year>2009</year><volume>41</volume><fpage>18</fpage><lpage>24</lpage><pub-id pub-id-type="pmid">19079260</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Willer</surname><given-names>CJ</given-names></name><name><surname>Speliotes</surname><given-names>EK</given-names></name><name><surname>Loos</surname><given-names>RJ</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Lindgren</surname><given-names>CM</given-names></name><name><surname>Heid</surname><given-names>IM</given-names></name><etal/></person-group><article-title>Six new loci associated with body mass index highlight a neuronal influence on body weight regulation</article-title><source>Nat Genet</source><year>2009</year><volume>41</volume><fpage>25</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">19079261</pub-id></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Franks</surname><given-names>PW</given-names></name><name><surname>Jablonski</surname><given-names>KA</given-names></name><name><surname>Delahanty</surname><given-names>LM</given-names></name><name><surname>McAteer</surname><given-names>JB</given-names></name><name><surname>Kahn</surname><given-names>SE</given-names></name><name><surname>Knowler</surname><given-names>WC</given-names></name><etal/></person-group><article-title>Assessing gene- treatment interactions at the FTO and INSIG2 loci on obesity-related traits in the Diabetes Prevention Program</article-title><source>Diabetologia</source><year>2008</year><volume>51</volume><fpage>2214</fpage><lpage>2223</lpage><pub-id pub-id-type="pmid">18839134</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delahanty</surname><given-names>LM</given-names></name><name><surname>Pan</surname><given-names>Q</given-names></name><name><surname>Jablonski</surname><given-names>KA</given-names></name><name><surname>Watson</surname><given-names>KE</given-names></name><name><surname>McCaffery</surname><given-names>JM</given-names></name><name><surname>Shuldiner</surname><given-names>A</given-names></name><etal/></person-group><article-title>Genetic predictors of weight loss and weight regain after intensive lifestyle modification, metformin treatment, or standard care in the Diabetes Prevention Program</article-title><source>Diabetes Care</source><year>2012</year><volume>35</volume><fpage>363</fpage><lpage>366</lpage><pub-id pub-id-type="pmid">22179955</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keating</surname><given-names>BJ</given-names></name><name><surname>Tischfield</surname><given-names>S</given-names></name><name><surname>Murray</surname><given-names>SS</given-names></name><name><surname>Bhangale</surname><given-names>T</given-names></name><name><surname>Price</surname><given-names>TS</given-names></name><name><surname>Glessner</surname><given-names>JT</given-names></name><etal/></person-group><article-title>Concept, design and implementation of a cardiovascular gene-centric 50 k SNP array for large-scale genomic association studies</article-title><source>PLoS One</source><year>2008</year><volume>3</volume><fpage>e3583</fpage><pub-id pub-id-type="pmid">18974833</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Espeland</surname><given-names>MA</given-names></name><name><surname>Dotson</surname><given-names>K</given-names></name><name><surname>Jaramillo</surname><given-names>SA</given-names></name><name><surname>Kahn</surname><given-names>SE</given-names></name><name><surname>Harrison</surname><given-names>B</given-names></name><name><surname>Montez</surname><given-names>M</given-names></name><etal/></person-group><article-title>Consent for genetics studies among clinical trial participants: findings from Action for Health in Diabetes (Look AHEAD)</article-title><source>Clin Trials</source><year>2006</year><volume>3</volume><fpage>443</fpage><lpage>456</lpage><pub-id pub-id-type="pmid">17060218</pub-id></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bray</surname><given-names>G</given-names></name><name><surname>Gregg</surname><given-names>E</given-names></name><name><surname>Haffner</surname><given-names>S</given-names></name><name><surname>Pi-Sunyer</surname><given-names>XF</given-names></name><name><surname>WagenKnecht</surname><given-names>LE</given-names></name><name><surname>Walkup</surname><given-names>M</given-names></name><etal/></person-group><article-title>Baseline characteristics of the randomised cohort from the Look AHEAD (Action for Health in Diabetes) study</article-title><source>Diab Vasc Dis Res</source><year>2006</year><volume>3</volume><fpage>202</fpage><lpage>215</lpage><pub-id pub-id-type="pmid">17160917</pub-id></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frayling</surname><given-names>TM</given-names></name><name><surname>Timpson</surname><given-names>NJ</given-names></name><name><surname>Weedon</surname><given-names>MN</given-names></name><name><surname>Zeggini</surname><given-names>E</given-names></name><name><surname>Freathy</surname><given-names>RM</given-names></name><name><surname>Lindgren</surname><given-names>CM</given-names></name><etal/></person-group><article-title>A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity</article-title><source>Science</source><year>2007</year><volume>316</volume><fpage>889</fpage><lpage>894</lpage><pub-id pub-id-type="pmid">17434869</pub-id></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herbert</surname><given-names>A</given-names></name><name><surname>Gerry</surname><given-names>NP</given-names></name><name><surname>McQueen</surname><given-names>MB</given-names></name><name><surname>Heid</surname><given-names>IM</given-names></name><name><surname>Pfeufer</surname><given-names>A</given-names></name><name><surname>Illig</surname><given-names>T</given-names></name><etal/></person-group><article-title>A common genetic variant is associated with adult and childhood obesity</article-title><source>Science</source><year>2006</year><volume>312</volume><fpage>279</fpage><lpage>283</lpage><pub-id pub-id-type="pmid">16614226</pub-id></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loos</surname><given-names>RJ</given-names></name><name><surname>Lindgren</surname><given-names>CM</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Wheeler</surname><given-names>E</given-names></name><name><surname>Zhao</surname><given-names>JH</given-names></name><name><surname>Prokopenko</surname><given-names>I</given-names></name><etal/></person-group><article-title>Common variants near MC4R are associated with fat mass, weight and risk of obesity</article-title><source>Nat Genet</source><year>2008</year><volume>40</volume><fpage>768</fpage><lpage>775</lpage><pub-id pub-id-type="pmid">18454148</pub-id></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scuteri</surname><given-names>A</given-names></name><name><surname>Sanna</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>WM</given-names></name><name><surname>Uda</surname><given-names>M</given-names></name><name><surname>Albai</surname><given-names>G</given-names></name><name><surname>Strait</surname><given-names>J</given-names></name><etal/></person-group><article-title>Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits</article-title><source>PLoS Genet</source><year>2007</year><volume>3</volume><fpage>e115</fpage><pub-id pub-id-type="pmid">17658951</pub-id></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sabatti</surname><given-names>C</given-names></name><name><surname>Service</surname><given-names>SK</given-names></name><name><surname>Hartikainen</surname><given-names>AL</given-names></name><name><surname>Pouta</surname><given-names>A</given-names></name><name><surname>Ripatti</surname><given-names>S</given-names></name><name><surname>Brodsky</surname><given-names>J</given-names></name><etal/></person-group><article-title>Genome-wide association analysis of metabolic traits in a birth cohort from a founder population</article-title><source>Nat Genet</source><year>2009</year><volume>41</volume><fpage>35</fpage><lpage>46</lpage><pub-id pub-id-type="pmid">19060910</pub-id></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dina</surname><given-names>C</given-names></name><name><surname>Meyre</surname><given-names>D</given-names></name><name><surname>Gallina</surname><given-names>S</given-names></name><name><surname>Durand</surname><given-names>E</given-names></name><name><surname>Korner</surname><given-names>A</given-names></name><name><surname>Jacobson</surname><given-names>P</given-names></name><etal/></person-group><article-title>Variation in FTO contributes to childhood obesity and severe adult obesity</article-title><source>Nat Genet</source><year>2007</year><volume>39</volume><fpage>724</fpage><lpage>726</lpage><pub-id pub-id-type="pmid">17496892</pub-id></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meyre</surname><given-names>D</given-names></name><name><surname>Delplanque</surname><given-names>J</given-names></name><name><surname>Chevre</surname><given-names>JC</given-names></name><name><surname>Lecoeur</surname><given-names>C</given-names></name><name><surname>Lobbens</surname><given-names>S</given-names></name><name><surname>Gallina</surname><given-names>S</given-names></name><etal/></person-group><article-title>Genome-wide association study for early-onset and morbid adult obesity identifies three new risk loci in European populations</article-title><source>Nat Genet</source><year>2009</year><volume>41</volume><fpage>157</fpage><lpage>159</lpage><pub-id pub-id-type="pmid">19151714</pub-id></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>AD</given-names></name><name><surname>Handsaker</surname><given-names>RE</given-names></name><name><surname>Pulit</surname><given-names>SL</given-names></name><name><surname>Nizzari</surname><given-names>MM</given-names></name><name><surname>O'Donnell</surname><given-names>CJ</given-names></name><name><surname>de Bakker</surname><given-names>PI</given-names></name></person-group><article-title>SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap</article-title><source>Bioinformatics</source><year>2008</year><volume>24</volume><fpage>2938</fpage><lpage>2939</lpage><pub-id pub-id-type="pmid">18974171</pub-id></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Price</surname><given-names>AL</given-names></name><name><surname>Patterson</surname><given-names>NJ</given-names></name><name><surname>Plenge</surname><given-names>RM</given-names></name><name><surname>Weinblatt</surname><given-names>ME</given-names></name><name><surname>Shadick</surname><given-names>NA</given-names></name><name><surname>Reich</surname><given-names>D</given-names></name></person-group><article-title>Principal components analysis corrects for stratification in genome-wide association studies</article-title><source>Nat Genet</source><year>2006</year><volume>38</volume><fpage>904</fpage><lpage>909</lpage><pub-id pub-id-type="pmid">16862161</pub-id></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McArdle</surname><given-names>PF</given-names></name><name><surname>Whitcomb</surname><given-names>BW</given-names></name></person-group><article-title>Improper adjustment for baseline in genetic association studies of change in phenotype</article-title><source>Human heredity</source><year>2009</year><volume>67</volume><fpage>176</fpage><lpage>182</lpage><pub-id pub-id-type="pmid">19077436</pub-id></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="book"><collab>TIBCO Software I</collab><source>TIBCO Spotfire SPLUS 8.2 for Solaris/Linux User's Guide</source><year>2010</year><publisher-loc>Seattle, WA</publisher-loc><publisher-name>TIBCO Software, Inc</publisher-name></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Ji</surname><given-names>L</given-names></name></person-group><article-title>Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix</article-title><source>Heredity</source><year>2005</year><volume>95</volume><fpage>221</fpage><lpage>227</lpage><pub-id pub-id-type="pmid">16077740</pub-id></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scott</surname><given-names>LJ</given-names></name><name><surname>Mohlke</surname><given-names>KL</given-names></name><name><surname>Bonnycastle</surname><given-names>LL</given-names></name><name><surname>Willer</surname><given-names>CJ</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Duren</surname><given-names>WL</given-names></name><etal/></person-group><article-title>A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants</article-title><source>Science</source><year>2007</year><volume>316</volume><fpage>1341</fpage><lpage>1345</lpage><pub-id pub-id-type="pmid">17463248</pub-id></element-citation></ref><ref id="R26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kilpelainen</surname><given-names>TO</given-names></name><name><surname>Qi</surname><given-names>L</given-names></name><name><surname>Brage</surname><given-names>S</given-names></name><name><surname>Sharp</surname><given-names>SJ</given-names></name><name><surname>Sonestedt</surname><given-names>E</given-names></name><name><surname>Demerath</surname><given-names>E</given-names></name><etal/></person-group><article-title>Physical activity attenuates the influence of FTO variants on obesity risk: a meta-analysis of 218,166 adults and 19,268 children</article-title><source>PLoS medicine</source><year>2011</year><volume>8</volume><fpage>e1001116</fpage><pub-id pub-id-type="pmid">22069379</pub-id></element-citation></ref><ref id="R27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Qi</surname><given-names>Q</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Hu</surname><given-names>FB</given-names></name><name><surname>Sacks</surname><given-names>FM</given-names></name><name><surname>Qi</surname><given-names>L</given-names></name></person-group><article-title>FTO Genotype and 2-Year Change in Body Composition and Fat Distribution in Response to Weight-Loss Diets: The POUNDS LOST Trial</article-title><source>Diabetes</source><year>2012</year></element-citation></ref><ref id="R28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bariohay</surname><given-names>B</given-names></name><name><surname>Roux</surname><given-names>J</given-names></name><name><surname>Tardivel</surname><given-names>C</given-names></name><name><surname>Trouslard</surname><given-names>J</given-names></name><name><surname>Jean</surname><given-names>A</given-names></name><name><surname>Lebrun</surname><given-names>B</given-names></name></person-group><article-title>Brain-derived neurotrophic factor/tropomyosin-related kinase receptor type B signaling is a downstream effector of the brainstem melanocortin system in food intake control</article-title><source>Endocrinology</source><year>2009</year><volume>150</volume><fpage>2646</fpage><lpage>2653</lpage><pub-id pub-id-type="pmid">19179431</pub-id></element-citation></ref><ref id="R29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lebrun</surname><given-names>B</given-names></name><name><surname>Bariohay</surname><given-names>B</given-names></name><name><surname>Moyse</surname><given-names>E</given-names></name><name><surname>Jean</surname><given-names>A</given-names></name></person-group><article-title>Brain-derived neurotrophic factor (BDNF) and food intake regulation: a minireview</article-title><source>Auton Neurosci</source><year>2006</year><volume>126&#x02013;127</volume><fpage>30</fpage><lpage>38</lpage></element-citation></ref><ref id="R30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Bomberg</surname><given-names>E</given-names></name><name><surname>Billington</surname><given-names>C</given-names></name><name><surname>Levine</surname><given-names>A</given-names></name><name><surname>Kotz</surname><given-names>CM</given-names></name></person-group><article-title>Brain-derived neurotrophic factor in the hypothalamic paraventricular nucleus reduces energy intake</article-title><source>Am J Physiol Regul Integr Comp Physiol</source><year>2007</year><volume>293</volume><fpage>R1003</fpage><lpage>R1012</lpage><pub-id pub-id-type="pmid">17581841</pub-id></element-citation></ref><ref id="R31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Bomberg</surname><given-names>E</given-names></name><name><surname>Levine</surname><given-names>A</given-names></name><name><surname>Billington</surname><given-names>C</given-names></name><name><surname>Kotz</surname><given-names>CM</given-names></name></person-group><article-title>Brain-derived neurotrophic factor in the ventromedial nucleus of the hypothalamus reduces energy intake</article-title><source>Am J Physiol Regul Integr Comp Physiol</source><year>2007</year><volume>293</volume><fpage>R1037</fpage><lpage>R1045</lpage><pub-id pub-id-type="pmid">17553842</pub-id></element-citation></ref><ref id="R32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fox</surname><given-names>EA</given-names></name><name><surname>Byerly</surname><given-names>MS</given-names></name></person-group><article-title>A mechanism underlying mature-onset obesity: evidence from the hyperphagic phenotype of brain-derived neurotrophic factor mutants</article-title><source>Am J Physiol Regul Integr Comp Physiol</source><year>2004</year><volume>286</volume><fpage>R994</fpage><lpage>R1004</lpage><pub-id pub-id-type="pmid">15142855</pub-id></element-citation></ref><ref id="R33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kernie</surname><given-names>SG</given-names></name><name><surname>Liebl</surname><given-names>DJ</given-names></name><name><surname>Parada</surname><given-names>LF</given-names></name></person-group><article-title>BDNF regulates eating behavior and locomotor activity in mice</article-title><source>EMBO J</source><year>2000</year><volume>19</volume><fpage>1290</fpage><lpage>1300</lpage><pub-id pub-id-type="pmid">10716929</pub-id></element-citation></ref><ref id="R34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lyons</surname><given-names>WE</given-names></name><name><surname>Mamounas</surname><given-names>LA</given-names></name><name><surname>Ricaurte</surname><given-names>GA</given-names></name><name><surname>Coppola</surname><given-names>V</given-names></name><name><surname>Reid</surname><given-names>SW</given-names></name><name><surname>Bora</surname><given-names>SH</given-names></name><etal/></person-group><article-title>Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities</article-title><source>Proc Natl Acad Sci U S A</source><year>1999</year><volume>96</volume><fpage>15239</fpage><lpage>1544</lpage><pub-id pub-id-type="pmid">10611369</pub-id></element-citation></ref><ref id="R35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Unger</surname><given-names>TJ</given-names></name><name><surname>Calderon</surname><given-names>GA</given-names></name><name><surname>Bradley</surname><given-names>LC</given-names></name><name><surname>Sena-Esteves</surname><given-names>M</given-names></name><name><surname>Rios</surname><given-names>M</given-names></name></person-group><article-title>Selective deletion of Bdnf in the ventromedial and dorsomedial hypothalamus of adult mice results in hyperphagic behavior and obesity</article-title><source>J Neurosci</source><year>2007</year><volume>27</volume><fpage>14265</fpage><lpage>14274</lpage><pub-id pub-id-type="pmid">18160634</pub-id></element-citation></ref><ref id="R36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>B</given-names></name><name><surname>Goulding</surname><given-names>EH</given-names></name><name><surname>Zang</surname><given-names>K</given-names></name><name><surname>Cepoi</surname><given-names>D</given-names></name><name><surname>Cone</surname><given-names>RD</given-names></name><name><surname>Jones</surname><given-names>KR</given-names></name><etal/></person-group><article-title>Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor</article-title><source>Nat Neurosci</source><year>2003</year><volume>6</volume><fpage>736</fpage><lpage>742</lpage><pub-id pub-id-type="pmid">12796784</pub-id></element-citation></ref><ref id="R37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCaffery</surname><given-names>JM</given-names></name><name><surname>Papandonatos</surname><given-names>GD</given-names></name><name><surname>Peter</surname><given-names>I</given-names></name><name><surname>Huggins</surname><given-names>GS</given-names></name><name><surname>Raynor</surname><given-names>HA</given-names></name><name><surname>Delahanty</surname><given-names>LM</given-names></name><etal/></person-group><article-title>Obesity susceptibility loci and dietary intake in the Look AHEAD Trial</article-title><source>Am J Clin Nutr</source><year>2012</year><volume>95</volume><fpage>1477</fpage><lpage>1486</lpage><pub-id pub-id-type="pmid">22513296</pub-id></element-citation></ref><ref id="R38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gray</surname><given-names>J</given-names></name><name><surname>Yeo</surname><given-names>GS</given-names></name><name><surname>Cox</surname><given-names>JJ</given-names></name><name><surname>Morton</surname><given-names>J</given-names></name><name><surname>Adlam</surname><given-names>AL</given-names></name><name><surname>Keogh</surname><given-names>JM</given-names></name><etal/></person-group><article-title>Hyperphagia, severe obesity, impaired cognitive function, and hyperactivity associated with functional loss of one copy of the brain-derived neurotrophic factor (BDNF) gene</article-title><source>Diabetes</source><year>2006</year><volume>55</volume><fpage>3366</fpage><lpage>3371</lpage><pub-id pub-id-type="pmid">17130481</pub-id></element-citation></ref></ref-list></back><floats-group><table-wrap id="T1" position="float" orientation="portrait"><label>Table 1</label><table frame="below" rules="groups"><thead><tr><th align="left" colspan="4" valign="bottom" rowspan="1">Population Characteristics in Look AHEAD Genetic Sub-Cohort<hr/></th></tr><tr><th align="left" rowspan="1" colspan="1">Characteristic</th><th align="right" rowspan="1" colspan="1">Total<break/>(N= 3,899)</th><th align="right" rowspan="1" colspan="1">DSE<break/>(N=1,964)</th><th align="right" rowspan="1" colspan="1">ILI<break/>(N=1,935)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Women (%)</td><td align="right" rowspan="1" colspan="1">2,192 (56.2)</td><td align="right" rowspan="1" colspan="1">1,096 (55.8)</td><td align="right" rowspan="1" colspan="1">1,096 (56.6)</td></tr><tr><td align="left" colspan="4" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Ethnicity (%)</td><td align="right" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;African American</td><td align="right" rowspan="1" colspan="1">618 (15.8)</td><td align="right" rowspan="1" colspan="1">305 (15.5)</td><td align="right" rowspan="1" colspan="1">313 (16.2)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;American Indian/Alaskan Native<xref ref-type="table-fn" rid="TFN1">a</xref></td><td align="right" rowspan="1" colspan="1">20 (0.5)</td><td align="right" rowspan="1" colspan="1">9 (0.5)</td><td align="right" rowspan="1" colspan="1">11 (0.6)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;Asian/Pacific Islander</td><td align="right" rowspan="1" colspan="1">41 (1.1)</td><td align="right" rowspan="1" colspan="1">19 (1.0)</td><td align="right" rowspan="1" colspan="1">22 (1.1)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;Hispanic/Latino</td><td align="right" rowspan="1" colspan="1">307 (7.9)</td><td align="right" rowspan="1" colspan="1">159 (8.1)</td><td align="right" rowspan="1" colspan="1">148 (7.7)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;Non-Hispanic White</td><td align="right" rowspan="1" colspan="1">2,835 (72.7)</td><td align="right" rowspan="1" colspan="1">1,430 (72.8)</td><td align="right" rowspan="1" colspan="1">1,405 (72.6)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;Other (multiple)</td><td align="right" rowspan="1" colspan="1">78 (2.0)</td><td align="right" rowspan="1" colspan="1">42 (2.1)</td><td align="right" rowspan="1" colspan="1">36 (1.9)</td></tr><tr><td align="left" colspan="4" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Age (years)</td><td align="right" rowspan="1" colspan="1">59.1&#x000b1;6.8</td><td align="right" rowspan="1" colspan="1">59.2&#x000b1;6.8</td><td align="right" rowspan="1" colspan="1">59.0&#x000b1;6.9</td></tr><tr><td align="left" colspan="4" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">BMI (kg/m<sup>2</sup>)</td><td align="right" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;Women</td><td align="right" rowspan="1" colspan="1">36.8&#x000b1;6.2</td><td align="right" rowspan="1" colspan="1">36.9&#x000b1;6.1</td><td align="right" rowspan="1" colspan="1">36.7&#x000b1;6.3</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;Men</td><td align="right" rowspan="1" colspan="1">35.3&#x000b1;5.5</td><td align="right" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;35.1&#x000b1;5.2</td><td align="right" rowspan="1" colspan="1">&#x000a0;&#x000a0;35.5&#x000b1;5.8</td></tr><tr><td align="left" colspan="4" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Waist circumference (cm)</td><td align="right" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;Women</td><td align="right" rowspan="1" colspan="1">111.4&#x000b1;13.7</td><td align="right" rowspan="1" colspan="1">111.5&#x000b1;13.6</td><td align="right" rowspan="1" colspan="1">111.3&#x000b1;13.8</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;Men</td><td align="right" rowspan="1" colspan="1">118.8&#x000b1;13.4</td><td align="right" rowspan="1" colspan="1">118.5&#x000b1;12.9</td><td align="right" rowspan="1" colspan="1">119.2&#x000b1;13.9</td></tr><tr><td align="left" colspan="4" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Weight at Y0 (kg)</td><td align="right" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;Women</td><td align="right" rowspan="1" colspan="1">96.7&#x000b1;17.5</td><td align="right" rowspan="1" colspan="1">96.6&#x000b1;17.4</td><td align="right" rowspan="1" colspan="1">96.8&#x000b1;17.7</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;Men</td><td align="right" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;109.6&#x000b1;18.5</td><td align="right" rowspan="1" colspan="1">109.4&#x000b1;17.8</td><td align="right" rowspan="1" colspan="1">109.8&#x000b1;19.2</td></tr><tr><td align="left" colspan="4" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Weight at Y1 (kg)</td><td align="right" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;Women</td><td align="right" rowspan="1" colspan="1">92.1&#x000b1;17.8</td><td align="right" rowspan="1" colspan="1">95.6&#x000b1;17.5</td><td align="right" rowspan="1" colspan="1">88.7&#x000b1;17.3</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;Men</td><td align="right" rowspan="1" colspan="1">104.1&#x000b1;18.9</td><td align="right" rowspan="1" colspan="1">108.7&#x000b1;17.9</td><td align="right" rowspan="1" colspan="1">99.4&#x000b1;18.8</td></tr><tr><td align="left" colspan="4" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Weight at Y4 (kg)</td><td align="right" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;Women</td><td align="right" rowspan="1" colspan="1">93.3&#x000b1;17.8</td><td align="right" rowspan="1" colspan="1">94.4&#x000b1;17.7</td><td align="right" rowspan="1" colspan="1">92.3&#x000b1;17.9</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;Men</td><td align="right" rowspan="1" colspan="1">106.1&#x000b1;19.1</td><td align="right" rowspan="1" colspan="1">108.4&#x000b1;18.2</td><td align="right" rowspan="1" colspan="1">103.7&#x000b1;19.7</td></tr><tr><td align="left" colspan="4" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Weight Change Y1-Y0 (kg)</td><td align="right" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;Women</td><td align="right" rowspan="1" colspan="1">&#x02212;4.6&#x000b1;7.1</td><td align="right" rowspan="1" colspan="1">&#x02212;0.9&#x000b1;5.1</td><td align="right" rowspan="1" colspan="1">&#x02212;8.1&#x000b1;7.1</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;Men</td><td align="right" rowspan="1" colspan="1">&#x02212;5.6&#x000b1;8.4</td><td align="right" rowspan="1" colspan="1">&#x02212;0.9&#x000b1;5.2</td><td align="right" rowspan="1" colspan="1">&#x02212;10.5&#x000b1;8.3</td></tr><tr><td align="left" colspan="4" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Weight Change Y4-Y0 (kg)</td><td align="right" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;Women</td><td align="right" rowspan="1" colspan="1">&#x02212;3.3&#x000b1;9.0</td><td align="right" rowspan="1" colspan="1">&#x02212;2.2&#x000b1;9.4</td><td align="right" rowspan="1" colspan="1">&#x02212;4.5&#x000b1;8.5</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;Men</td><td align="right" rowspan="1" colspan="1">&#x02212;3.3&#x000b1;8.8</td><td align="right" rowspan="1" colspan="1">&#x02212;0.9&#x000b1;7.8</td><td align="right" rowspan="1" colspan="1">&#x02212;5.8&#x000b1;9.0</td></tr></tbody></table><table frame="below" rules="groups"><thead><tr><th align="left" colspan="4" valign="bottom" rowspan="1">a. Population Characteristics among individuals who lost 3% or more of baseline weight at year 1<hr/></th></tr><tr><th align="left" rowspan="1" colspan="1">Characteristic</th><th align="right" rowspan="1" colspan="1">Total<break/>(N= 2,022)</th><th align="right" rowspan="1" colspan="1">DSE<break/>(N=477)</th><th align="right" rowspan="1" colspan="1">ILI<break/>N=1,545)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Women (%)</td><td align="right" rowspan="1" colspan="1">1,151 (56.9)</td><td align="right" rowspan="1" colspan="1">287 (60.2)</td><td align="right" rowspan="1" colspan="1">864 (55.9)</td></tr><tr><td align="left" colspan="4" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Ethnicity (%)</td><td align="right" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;African American</td><td align="right" rowspan="1" colspan="1">300 (14.8)</td><td align="right" rowspan="1" colspan="1">64 (13.4)</td><td align="right" rowspan="1" colspan="1">236 (15.3)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;American Indian/Alaskan Native<xref ref-type="table-fn" rid="TFN1">a</xref></td><td align="right" rowspan="1" colspan="1">8 (0.4)</td><td align="right" rowspan="1" colspan="1">2 (0.4)</td><td align="right" rowspan="1" colspan="1">6 (0.4)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;Asian/Pacific Islander</td><td align="right" rowspan="1" colspan="1">21 (1.0)</td><td align="right" rowspan="1" colspan="1">3 (0.6)</td><td align="right" rowspan="1" colspan="1">18 (1.2)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;Hispanic/Latino</td><td align="right" rowspan="1" colspan="1">145 (7.2)</td><td align="right" rowspan="1" colspan="1">39 (8.2)</td><td align="right" rowspan="1" colspan="1">106 (6.9)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;Non-Hispanic White</td><td align="right" rowspan="1" colspan="1">1,511 (74.7)</td><td align="right" rowspan="1" colspan="1">360 (75.5)</td><td align="right" rowspan="1" colspan="1">1151 (74.5)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;Other (multiple)</td><td align="right" rowspan="1" colspan="1">37 (1.8)</td><td align="right" rowspan="1" colspan="1">9 (1.9)</td><td align="right" rowspan="1" colspan="1">28 (1.8)</td></tr><tr><td align="left" colspan="4" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Age at Y1 (years)</td><td align="right" rowspan="1" colspan="1">61.0&#x000b1;6.9</td><td align="right" rowspan="1" colspan="1">61.1&#x000b1;6.8</td><td align="right" rowspan="1" colspan="1">61.0&#x000b1;6.9</td></tr><tr><td align="left" colspan="4" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">BMI at Y1 (kg/m<sup>2</sup>)</td><td align="right" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;Women</td><td align="right" rowspan="1" colspan="1">33.2&#x000b1;5.9</td><td align="right" rowspan="1" colspan="1">34.9&#x000b1;6.0</td><td align="right" rowspan="1" colspan="1">32.6&#x000b1;5.8</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;Men</td><td align="right" rowspan="1" colspan="1">31.7&#x000b1;5.5</td><td align="right" rowspan="1" colspan="1">33.2&#x000b1;5.0</td><td align="right" rowspan="1" colspan="1">31.3&#x000b1;5.5</td></tr><tr><td align="left" colspan="4" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Waist circumference at Y1 (cm)</td><td align="right" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;Women</td><td align="right" rowspan="1" colspan="1">103.6&#x000b1;13.4</td><td align="right" rowspan="1" colspan="1">107.4&#x000b1;13.3</td><td align="right" rowspan="1" colspan="1">102.4&#x000b1;13.2</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;Men</td><td align="right" rowspan="1" colspan="1">109.3&#x000b1;14.0</td><td align="right" rowspan="1" colspan="1">114.1&#x000b1;12.9</td><td align="right" rowspan="1" colspan="1">107.9&#x000b1;14.1</td></tr><tr><td align="left" colspan="4" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Weight at Y1 (kg)</td><td align="right" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;Women</td><td align="right" rowspan="1" colspan="1">87.4&#x000b1;16.5</td><td align="right" rowspan="1" colspan="1">91.3&#x000b1;17.3</td><td align="right" rowspan="1" colspan="1">86.1&#x000b1;16.0</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;Men</td><td align="right" rowspan="1" colspan="1">98.5&#x000b1;18.0</td><td align="right" rowspan="1" colspan="1">104.2&#x000b1;17.0</td><td align="right" rowspan="1" colspan="1">96.9&#x000b1;18.0</td></tr><tr><td align="left" colspan="4" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Weight at Y4 (kg)</td><td align="right" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;Women</td><td align="right" rowspan="1" colspan="1">91.1&#x000b1;17.4</td><td align="right" rowspan="1" colspan="1">91.8&#x000b1;17.2</td><td align="right" rowspan="1" colspan="1">90.8&#x000b1;17.4</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;Men</td><td align="right" rowspan="1" colspan="1">103.3&#x000b1;19.1</td><td align="right" rowspan="1" colspan="1">106.6&#x000b1;17.6</td><td align="right" rowspan="1" colspan="1">102.4&#x000b1;19.4</td></tr><tr><td align="left" colspan="4" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Weight Change Y4-Y1 (kg)</td><td align="right" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;Women</td><td align="right" rowspan="1" colspan="1">3.7&#x000b1;8.2</td><td align="right" rowspan="1" colspan="1">0.5&#x000b1;9.1</td><td align="right" rowspan="1" colspan="1">4.7&#x000b1;7.6</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;Men</td><td align="right" rowspan="1" colspan="1">4.8&#x000b1;7.8</td><td align="right" rowspan="1" colspan="1">2.4&#x000b1;7.0</td><td align="right" rowspan="1" colspan="1">&#x000a0;&#x000a0;5.5&#x000b1;7.8</td></tr><tr><td align="left" colspan="4" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Weight Regain Y4-Y1 (%)<xref ref-type="table-fn" rid="TFN2">b</xref></td><td align="right" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;Women</td><td align="right" rowspan="1" colspan="1">834 (72.5)</td><td align="right" rowspan="1" colspan="1">157 (54.7)</td><td align="right" rowspan="1" colspan="1">677 (78.4)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;Men</td><td align="right" rowspan="1" colspan="1">684 (78.5)</td><td align="right" rowspan="1" colspan="1">123 (64.7)</td><td align="right" rowspan="1" colspan="1">561 (82.4)</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><label>a</label><p id="P73">The number of American Indian participants included in this study is less than that of the parent Look AHEAD trial due to limitations in genetic consent.</p></fn><fn id="TFN2"><label>b</label><p id="P74">Percentage of individuals who gained weight (&#x0003e;0 kgs) from year 1 &#x02013; year 4.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T2" position="float" orientation="landscape"><label>Table 2</label><caption><p id="P75">SNP characteristics in the full genetic sample and two most common racial groups: Non-Hispanic Whites and African-Americans.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1"/><th align="center" colspan="2" valign="bottom" rowspan="1">Full Sample<break/>(N = 3,899)<hr/></th><th align="center" colspan="2" valign="bottom" rowspan="1">American<break/>Non-Hispanic<break/>Whites<break/>(N = 2,835)<hr/></th><th align="center" colspan="2" valign="bottom" rowspan="1">African<break/>American<break/>(N = 618)<hr/></th><th align="center" rowspan="1" colspan="1"/></tr><tr><th align="center" rowspan="1" colspan="1">Chr</th><th align="left" rowspan="1" colspan="1">Positional<break/>candidate<break/>gene</th><th align="left" rowspan="1" colspan="1">SNP</th><th align="center" rowspan="1" colspan="1">Risk<break/>allele</th><th align="center" rowspan="1" colspan="1">Major/<break/>Minor<break/>Allele</th><th align="center" rowspan="1" colspan="1">MAF<xref ref-type="table-fn" rid="TFN3">a</xref></th><th align="center" rowspan="1" colspan="1">Major/<break/>Minor<break/>Allele</th><th align="center" rowspan="1" colspan="1">MAF<xref ref-type="table-fn" rid="TFN3">a</xref></th><th align="center" rowspan="1" colspan="1">Major/<break/>Minor<break/>Allele</th><th align="center" rowspan="1" colspan="1">MAF<xref ref-type="table-fn" rid="TFN3">a</xref></th><th align="center" rowspan="1" colspan="1">Reference<break/>PMID;<break/>year</th></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1"><italic>TNNI3K</italic></td><td align="left" rowspan="1" colspan="1">rs1514176<xref ref-type="table-fn" rid="TFN4">b</xref></td><td align="center" rowspan="1" colspan="1">G</td><td align="center" rowspan="1" colspan="1">A/G</td><td align="center" rowspan="1" colspan="1">0.48</td><td align="center" rowspan="1" colspan="1">A/G</td><td align="center" rowspan="1" colspan="1">0.43</td><td align="center" rowspan="1" colspan="1">G/A</td><td align="center" rowspan="1" colspan="1">0.34</td><td align="center" rowspan="1" colspan="1">20935630;<break/>2010</td></tr><tr><td align="left" colspan="11" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="center" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1"><italic>TFAP2B</italic></td><td align="left" rowspan="1" colspan="1">rs2272903</td><td align="center" rowspan="1" colspan="1">G</td><td align="center" rowspan="1" colspan="1">G/A</td><td align="center" rowspan="1" colspan="1">0.14</td><td align="center" rowspan="1" colspan="1">G/A</td><td align="center" rowspan="1" colspan="1">0.11</td><td align="center" rowspan="1" colspan="1">G/A</td><td align="center" rowspan="1" colspan="1">0.28</td><td align="center" rowspan="1" colspan="1">20935630;<break/>2010</td></tr><tr><td align="left" colspan="11" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="center" rowspan="1" colspan="1">11</td><td align="left" rowspan="1" colspan="1"><italic>BDNF</italic></td><td align="left" rowspan="1" colspan="1">rs6265</td><td align="center" rowspan="1" colspan="1">G</td><td align="center" rowspan="1" colspan="1">G/A</td><td align="center" rowspan="1" colspan="1">0.16</td><td align="center" rowspan="1" colspan="1">G/A</td><td align="center" rowspan="1" colspan="1">0.18</td><td align="center" rowspan="1" colspan="1">G/A</td><td align="center" rowspan="1" colspan="1">0.05</td><td align="center" rowspan="1" colspan="1">19079260;<break/>2009</td></tr><tr><td align="left" colspan="11" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="center" rowspan="1" colspan="1">11</td><td align="left" rowspan="1" colspan="1"><italic>BDNF</italic></td><td align="left" rowspan="1" colspan="1">rs1401635<xref ref-type="table-fn" rid="TFN5">c</xref></td><td align="center" rowspan="1" colspan="1">C</td><td align="center" rowspan="1" colspan="1">G/C</td><td align="center" rowspan="1" colspan="1">0.29</td><td align="center" rowspan="1" colspan="1">G/C</td><td align="center" rowspan="1" colspan="1">0.31</td><td align="center" rowspan="1" colspan="1">G/C</td><td align="center" rowspan="1" colspan="1">0.26</td><td align="center" rowspan="1" colspan="1">19079260;<break/>2009</td></tr><tr><td align="left" colspan="11" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="center" rowspan="1" colspan="1">11</td><td align="left" rowspan="1" colspan="1"><italic>BDNF</italic></td><td align="left" rowspan="1" colspan="1">rs10767664</td><td align="center" rowspan="1" colspan="1">A</td><td align="center" rowspan="1" colspan="1">A/T</td><td align="center" rowspan="1" colspan="1">0.19</td><td align="center" rowspan="1" colspan="1">A/T</td><td align="center" rowspan="1" colspan="1">0.21</td><td align="center" rowspan="1" colspan="1">A/T</td><td align="center" rowspan="1" colspan="1">0.07</td><td align="center" rowspan="1" colspan="1">19079260;<break/>2009</td></tr><tr><td align="left" colspan="11" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="center" rowspan="1" colspan="1">13</td><td align="left" rowspan="1" colspan="1"><italic>MTIF3</italic></td><td align="left" rowspan="1" colspan="1">rs7988412<xref ref-type="table-fn" rid="TFN6">d</xref></td><td align="center" rowspan="1" colspan="1">A</td><td align="center" rowspan="1" colspan="1">G/A</td><td align="center" rowspan="1" colspan="1">0.18</td><td align="center" rowspan="1" colspan="1">G/A</td><td align="center" rowspan="1" colspan="1">0.17</td><td align="center" rowspan="1" colspan="1">G/A</td><td align="center" rowspan="1" colspan="1">0.20</td><td align="center" rowspan="1" colspan="1">20935630;<break/>2010</td></tr><tr><td align="left" colspan="11" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="center" rowspan="1" colspan="1">16</td><td align="left" rowspan="1" colspan="1"><italic>SH2B1</italic></td><td align="left" rowspan="1" colspan="1">rs4788099<xref ref-type="table-fn" rid="TFN7">e</xref></td><td align="center" rowspan="1" colspan="1">G</td><td align="center" rowspan="1" colspan="1">A/G</td><td align="center" rowspan="1" colspan="1">0.37</td><td align="center" rowspan="1" colspan="1">A/G</td><td align="center" rowspan="1" colspan="1">0.38</td><td align="center" rowspan="1" colspan="1">A/G</td><td align="center" rowspan="1" colspan="1">0.29</td><td align="center" rowspan="1" colspan="1">20935630;<break/>2010</td></tr><tr><td align="left" colspan="11" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="center" rowspan="1" colspan="1">16</td><td align="left" rowspan="1" colspan="1"><italic>FTO</italic></td><td align="left" rowspan="1" colspan="1">rs1421085</td><td align="center" rowspan="1" colspan="1">C</td><td align="center" rowspan="1" colspan="1">T/C</td><td align="center" rowspan="1" colspan="1">0.39</td><td align="center" rowspan="1" colspan="1">T/C</td><td align="center" rowspan="1" colspan="1">0.46</td><td align="center" rowspan="1" colspan="1">T/C</td><td align="center" rowspan="1" colspan="1">0.14</td><td align="center" rowspan="1" colspan="1">17496892;<break/>2007</td></tr><tr><td align="left" colspan="11" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="center" rowspan="1" colspan="1">16</td><td align="left" rowspan="1" colspan="1"><italic>FTO</italic></td><td align="left" rowspan="1" colspan="1">rs3751812</td><td align="center" rowspan="1" colspan="1">A</td><td align="center" rowspan="1" colspan="1">C/A</td><td align="center" rowspan="1" colspan="1">0.38</td><td align="center" rowspan="1" colspan="1">C/A</td><td align="center" rowspan="1" colspan="1">0.45</td><td align="center" rowspan="1" colspan="1">C/A</td><td align="center" rowspan="1" colspan="1">0.13</td><td align="center" rowspan="1" colspan="1">19079260;<break/>2009</td></tr><tr><td align="left" colspan="11" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="center" rowspan="1" colspan="1">16</td><td align="left" rowspan="1" colspan="1"><italic>FTO</italic></td><td align="left" rowspan="1" colspan="1">rs9939609</td><td align="center" rowspan="1" colspan="1">A</td><td align="center" rowspan="1" colspan="1">T/A</td><td align="center" rowspan="1" colspan="1">0.44</td><td align="center" rowspan="1" colspan="1">T/A</td><td align="center" rowspan="1" colspan="1">0.45</td><td align="center" rowspan="1" colspan="1">T/A</td><td align="center" rowspan="1" colspan="1">0.49</td><td align="center" rowspan="1" colspan="1">17434869;<break/>2007</td></tr><tr><td align="left" colspan="11" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="center" rowspan="1" colspan="1">16</td><td align="left" rowspan="1" colspan="1"><italic>FTO</italic></td><td align="left" rowspan="1" colspan="1">rs9922708<xref ref-type="table-fn" rid="TFN8">f</xref></td><td align="center" rowspan="1" colspan="1">A</td><td align="center" rowspan="1" colspan="1">G/A</td><td align="center" rowspan="1" colspan="1">0.43</td><td align="center" rowspan="1" colspan="1">G/A</td><td align="center" rowspan="1" colspan="1">0.49</td><td align="center" rowspan="1" colspan="1">G/A</td><td align="center" rowspan="1" colspan="1">0.24</td><td align="center" rowspan="1" colspan="1">17658951;<break/>2007</td></tr><tr><td align="left" colspan="11" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="center" rowspan="1" colspan="1">18</td><td align="left" rowspan="1" colspan="1"><italic>MC4R</italic></td><td align="left" rowspan="1" colspan="1">rs17782313</td><td align="center" rowspan="1" colspan="1">C</td><td align="center" rowspan="1" colspan="1">T/C</td><td align="center" rowspan="1" colspan="1">0.25</td><td align="center" rowspan="1" colspan="1">T/C</td><td align="center" rowspan="1" colspan="1">0.25</td><td align="center" rowspan="1" colspan="1">T/C</td><td align="center" rowspan="1" colspan="1">0.29</td><td align="center" rowspan="1" colspan="1">18454148;<break/>2008</td></tr><tr><td align="left" colspan="11" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="center" rowspan="1" colspan="1">19</td><td align="left" rowspan="1" colspan="1"><italic>QPCTL/GIPR</italic></td><td align="left" rowspan="1" colspan="1">rs11672660<xref ref-type="table-fn" rid="TFN9">g</xref></td><td align="center" rowspan="1" colspan="1">G</td><td align="center" rowspan="1" colspan="1">G/A</td><td align="center" rowspan="1" colspan="1">0.18</td><td align="center" rowspan="1" colspan="1">G/A</td><td align="center" rowspan="1" colspan="1">0.21</td><td align="center" rowspan="1" colspan="1">G/A</td><td align="center" rowspan="1" colspan="1">0.10</td><td align="center" rowspan="1" colspan="1">20935630;<break/>2010</td></tr></tbody></table><table-wrap-foot><fn id="TFN3"><label>a</label><p id="P76">MAF &#x02013; minor allele frequency</p></fn><fn id="TFN4"><label>b</label><p id="P77"><italic>TNNI3K</italic> rs1514175 was replaced by rs1514176 (distance 48 bp, r<sup>2</sup>=1.00, D&#x02019;=1.00 in CEU and r<sup>2</sup>=1.00, D&#x02019;=1.00 in YRI).</p></fn><fn id="TFN5"><label>c</label><p id="P78"><italic>BDNF</italic> rs925946 was replaced by rs1401635 (distance 26,789 bp r<sup>2</sup>=0.96, D&#x02019;=1.00 in CEU; no proxy was available in YRI).</p></fn><fn id="TFN6"><label>d</label><p id="P79"><italic>MTIF3</italic> rs4771122 was replaced by rs7988412 (distance 19898, r<sup>2</sup>=0.83, D&#x02019;=1.00 in CEU; no proxy was available in YRI).</p></fn><fn id="TFN7"><label>e</label><p id="P80"><italic>SH2B1</italic> rs7498665 was replaced by rs4788099 (distance 27,514 bp r<sup>2</sup>=1.00, D&#x02019;=1.00 in CEU and D&#x02019;=1.00 and r<sup>2</sup>=0.94 in YRI).</p></fn><fn id="TFN8"><label>f</label><p id="P81"><italic>FTO</italic> rs9930506 was replaced by rs9922708 (distance 681 bp r<sup>2</sup>=1.00, D&#x02019;=1.00 in both CEU and YRI).</p></fn><fn id="TFN9"><label>g</label><p id="P82"><italic>QPCTL/GIPR</italic> rs2287019 was replaced by rs11672660 (distance 21988 bp, r<sup>2</sup>=0.83, D&#x02019;=1.00 in CEU, r<sup>2</sup>=0.89, D&#x02019;=1.00 in YRI).</p></fn></table-wrap-foot></table-wrap><table-wrap id="T3" position="float" orientation="landscape"><label>Table 3</label><caption><p id="P83">Genetic predictors of baseline weight (in kg; N = 3,899). Age, gender, ancestry principal components and study site statistically adjusted.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">Weight<break/>(in kgs)</th><th align="center" rowspan="1" colspan="1"/><th align="center" colspan="3" rowspan="1">Body mass index<break/>(kg/m<sup>2</sup>)</th></tr><tr><th align="center" valign="bottom" rowspan="1" colspan="1">Chr.</th><th align="center" valign="bottom" rowspan="1" colspan="1">Gene</th><th align="left" valign="bottom" rowspan="1" colspan="1">SNP</th><th align="center" rowspan="1" colspan="1">Minor<break/>allele</th><th align="center" valign="bottom" rowspan="1" colspan="1">Value</th><th align="center" rowspan="1" colspan="1">Std.<break/>Error</th><th align="center" valign="bottom" rowspan="1" colspan="1">P<break/>Value</th><th align="center" valign="bottom" rowspan="1" colspan="1">Value</th><th align="center" rowspan="1" colspan="1">Std.<break/>Error</th><th align="center" valign="bottom" rowspan="1" colspan="1">P<break/>Value</th></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1"><italic>TNNI3K</italic></td><td align="left" rowspan="1" colspan="1">rs1514176</td><td align="center" rowspan="1" colspan="1">G</td><td align="center" rowspan="1" colspan="1">&#x02212;0.054</td><td align="center" rowspan="1" colspan="1">0.398</td><td align="center" rowspan="1" colspan="1">0.892</td><td align="center" rowspan="1" colspan="1">&#x02212;0.016</td><td align="center" rowspan="1" colspan="1">0.134</td><td align="center" rowspan="1" colspan="1">0.906</td></tr><tr><td align="left" colspan="10" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1"><italic>TFAP2B</italic></td><td align="left" rowspan="1" colspan="1">rs2272903</td><td align="center" rowspan="1" colspan="1">A</td><td align="center" rowspan="1" colspan="1">&#x02212;0.862</td><td align="center" rowspan="1" colspan="1">0.577</td><td align="center" rowspan="1" colspan="1">0.135</td><td align="center" rowspan="1" colspan="1">&#x02212;0.212</td><td align="center" rowspan="1" colspan="1">0.194</td><td align="center" rowspan="1" colspan="1">0.274</td></tr><tr><td align="left" colspan="10" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1"><italic>BDNF</italic></td><td align="left" rowspan="1" colspan="1">rs6265</td><td align="center" rowspan="1" colspan="1">A</td><td align="center" rowspan="1" colspan="1">&#x02212;0.739</td><td align="center" rowspan="1" colspan="1">0.547</td><td align="center" rowspan="1" colspan="1">0.177</td><td align="center" rowspan="1" colspan="1">&#x02212;0.231</td><td align="center" rowspan="1" colspan="1">0.183</td><td align="center" rowspan="1" colspan="1">0.207</td></tr><tr><td align="left" colspan="10" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1"><italic>BDNF</italic></td><td align="left" rowspan="1" colspan="1">rs1401635</td><td align="center" rowspan="1" colspan="1">C</td><td align="center" rowspan="1" colspan="1">&#x02212;0.173</td><td align="center" rowspan="1" colspan="1">0.429</td><td align="center" rowspan="1" colspan="1">0.687</td><td align="center" rowspan="1" colspan="1">&#x02212;0.038</td><td align="center" rowspan="1" colspan="1">0.144</td><td align="center" rowspan="1" colspan="1">0.794</td></tr><tr><td align="left" colspan="10" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1"><italic>BDNF</italic></td><td align="left" rowspan="1" colspan="1">rs10767664</td><td align="center" rowspan="1" colspan="1">T</td><td align="center" rowspan="1" colspan="1">&#x02212;0.642</td><td align="center" rowspan="1" colspan="1">0.511</td><td align="center" rowspan="1" colspan="1">0.209</td><td align="center" rowspan="1" colspan="1">&#x02212;0.188</td><td align="center" rowspan="1" colspan="1">0.171</td><td align="center" rowspan="1" colspan="1">0.272</td></tr><tr><td align="left" colspan="10" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1"><italic>MTIF3</italic></td><td align="left" rowspan="1" colspan="1">rs7988412</td><td align="center" rowspan="1" colspan="1">A</td><td align="center" rowspan="1" colspan="1">0.009</td><td align="center" rowspan="1" colspan="1">0.520</td><td align="center" rowspan="1" colspan="1">0.986</td><td align="center" rowspan="1" colspan="1">&#x02212;0.115</td><td align="center" rowspan="1" colspan="1">0.175</td><td align="center" rowspan="1" colspan="1">0.511</td></tr><tr><td align="left" colspan="10" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1"><italic>SH2B1</italic></td><td align="left" rowspan="1" colspan="1">rs4788099</td><td align="center" rowspan="1" colspan="1">G</td><td align="center" rowspan="1" colspan="1">1.014</td><td align="center" rowspan="1" colspan="1">0.404</td><td align="center" rowspan="1" colspan="1"><bold>0.012</bold></td><td align="center" rowspan="1" colspan="1">0.191</td><td align="center" rowspan="1" colspan="1">0.135</td><td align="center" rowspan="1" colspan="1">0.159</td></tr><tr><td align="left" colspan="10" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1"><italic>FTO</italic></td><td align="left" rowspan="1" colspan="1">rs1421085</td><td align="center" rowspan="1" colspan="1">C</td><td align="center" rowspan="1" colspan="1">1.263</td><td align="center" rowspan="1" colspan="1">0.415</td><td align="center" rowspan="1" colspan="1"><bold>0.002</bold></td><td align="center" rowspan="1" colspan="1">0.463</td><td align="center" rowspan="1" colspan="1">0.139</td><td align="center" rowspan="1" colspan="1"><bold>0.001</bold></td></tr><tr><td align="left" colspan="10" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1"><italic>FTO</italic></td><td align="left" rowspan="1" colspan="1">rs3751812</td><td align="center" rowspan="1" colspan="1">A</td><td align="center" rowspan="1" colspan="1">1.143</td><td align="center" rowspan="1" colspan="1">0.416</td><td align="center" rowspan="1" colspan="1"><bold>0.006</bold></td><td align="center" rowspan="1" colspan="1">0.432</td><td align="center" rowspan="1" colspan="1">0.139</td><td align="center" rowspan="1" colspan="1"><bold>0.002</bold></td></tr><tr><td align="left" colspan="10" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1"><italic>FTO</italic></td><td align="left" rowspan="1" colspan="1">rs9939609</td><td align="center" rowspan="1" colspan="1">A</td><td align="center" rowspan="1" colspan="1">1.013</td><td align="center" rowspan="1" colspan="1">0.394</td><td align="center" rowspan="1" colspan="1"><bold>0.010</bold></td><td align="center" rowspan="1" colspan="1">0.381</td><td align="center" rowspan="1" colspan="1">0.132</td><td align="center" rowspan="1" colspan="1"><bold>0.004</bold></td></tr><tr><td align="left" colspan="10" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1"><italic>FTO</italic></td><td align="left" rowspan="1" colspan="1">rs9922708</td><td align="center" rowspan="1" colspan="1">A</td><td align="center" rowspan="1" colspan="1">1.245</td><td align="center" rowspan="1" colspan="1">0.405</td><td align="center" rowspan="1" colspan="1"><bold>0.002</bold></td><td align="center" rowspan="1" colspan="1">0.440</td><td align="center" rowspan="1" colspan="1">0.136</td><td align="center" rowspan="1" colspan="1"><bold>0.001</bold></td></tr><tr><td align="left" colspan="10" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="center" rowspan="1" colspan="1">18</td><td align="center" rowspan="1" colspan="1"><italic>MC4R</italic></td><td align="left" rowspan="1" colspan="1">rs17782313</td><td align="center" rowspan="1" colspan="1">C</td><td align="center" rowspan="1" colspan="1">0.550</td><td align="center" rowspan="1" colspan="1">0.459</td><td align="center" rowspan="1" colspan="1">0.230</td><td align="center" rowspan="1" colspan="1">0.550</td><td align="center" rowspan="1" colspan="1">0.459</td><td align="center" rowspan="1" colspan="1">0.230</td></tr><tr><td align="left" colspan="10" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="center" rowspan="1" colspan="1">19</td><td align="center" rowspan="1" colspan="1"><italic>QPCTL/GIPR</italic></td><td align="left" rowspan="1" colspan="1">rs11672660</td><td align="center" rowspan="1" colspan="1">A</td><td align="center" rowspan="1" colspan="1">&#x02212;1.282</td><td align="center" rowspan="1" colspan="1">0.510</td><td align="center" rowspan="1" colspan="1"><bold>0.012</bold></td><td align="center" rowspan="1" colspan="1">&#x02212;0.461</td><td align="center" rowspan="1" colspan="1">0.171</td><td align="center" rowspan="1" colspan="1"><bold>0.007</bold></td></tr></tbody></table></table-wrap><table-wrap id="T4" position="float" orientation="landscape"><label>Table 4</label><caption><p id="P84">Genetic predictors of year 1&#x02013;4 weight change (in kg) among those who lost 3% or greater of initial weight (Total N = 2022; ILI N = 1545; DSE N=477). Age, gender, ancestry principal components, study site and year 1 weight statistically adjusted.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" rowspan="1" colspan="1">Chr</th><th align="center" rowspan="1" colspan="1">Gene</th><th align="left" rowspan="1" colspan="1">SNP</th><th align="center" rowspan="1" colspan="1">Minor<break/>allele</th><th align="right" rowspan="1" colspan="1">Effect</th><th align="right" rowspan="1" colspan="1">Beta</th><th align="right" rowspan="1" colspan="1">Std.<break/>Error</th><th align="right" rowspan="1" colspan="1">P<break/>value</th></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1"><italic>TNNI3K</italic></td><td align="left" rowspan="1" colspan="1">rs1514176</td><td align="center" rowspan="1" colspan="1">G</td><td align="right" rowspan="1" colspan="1">ILI<xref ref-type="table-fn" rid="TFN10">a</xref></td><td align="right" rowspan="1" colspan="1">0.204</td><td align="right" rowspan="1" colspan="1">0.292</td><td align="right" rowspan="1" colspan="1">0.486</td></tr><tr><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1">DSE<xref ref-type="table-fn" rid="TFN11">b</xref></td><td align="right" rowspan="1" colspan="1">0.334</td><td align="right" rowspan="1" colspan="1">0.501</td><td align="right" rowspan="1" colspan="1">0.512</td></tr><tr><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1">Avg<xref ref-type="table-fn" rid="TFN12">c</xref></td><td align="right" rowspan="1" colspan="1">0.269</td><td align="right" rowspan="1" colspan="1">0.294</td><td align="right" rowspan="1" colspan="1">0.360</td></tr><tr><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1">ILI-DSE<xref ref-type="table-fn" rid="TFN13">d</xref></td><td align="right" rowspan="1" colspan="1">&#x02212;0.130</td><td align="right" rowspan="1" colspan="1">0.586</td><td align="right" rowspan="1" colspan="1">0.825</td></tr><tr><td align="left" colspan="8" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1"><italic>TFAP2B</italic></td><td align="left" rowspan="1" colspan="1">rs2272903</td><td align="center" rowspan="1" colspan="1">A</td><td align="right" rowspan="1" colspan="1">ILI</td><td align="right" rowspan="1" colspan="1">0.122</td><td align="right" rowspan="1" colspan="1">0.417</td><td align="right" rowspan="1" colspan="1">0.769</td></tr><tr><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1">DSE</td><td align="right" rowspan="1" colspan="1">0.095</td><td align="right" rowspan="1" colspan="1">0.800</td><td align="right" rowspan="1" colspan="1">0.906</td></tr><tr><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1">Avg</td><td align="right" rowspan="1" colspan="1">0.109</td><td align="right" rowspan="1" colspan="1">0.451</td><td align="right" rowspan="1" colspan="1">0.810</td></tr><tr><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1">ILI-DSE</td><td align="right" rowspan="1" colspan="1">0.028</td><td align="right" rowspan="1" colspan="1">0.902</td><td align="right" rowspan="1" colspan="1">0.976</td></tr><tr><td align="left" colspan="8" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1"><italic>BDNF</italic></td><td align="left" rowspan="1" colspan="1">rs6265</td><td align="center" rowspan="1" colspan="1">A</td><td align="right" rowspan="1" colspan="1">ILI</td><td align="right" rowspan="1" colspan="1">&#x02212;0.397</td><td align="right" rowspan="1" colspan="1">0.399</td><td align="right" rowspan="1" colspan="1">0.320</td></tr><tr><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1">DSE</td><td align="right" rowspan="1" colspan="1">&#x02212;1.150</td><td align="right" rowspan="1" colspan="1">0.685</td><td align="right" rowspan="1" colspan="1">0.094</td></tr><tr><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1">Avg</td><td align="right" rowspan="1" colspan="1">&#x02212;0.773</td><td align="right" rowspan="1" colspan="1">0.397</td><td align="right" rowspan="1" colspan="1">0.051</td></tr><tr><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1">ILI-DSE</td><td align="right" rowspan="1" colspan="1">0.753</td><td align="right" rowspan="1" colspan="1">0.793</td><td align="right" rowspan="1" colspan="1">0.343</td></tr><tr><td align="left" colspan="8" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1"><italic>BDNF</italic></td><td align="left" rowspan="1" colspan="1">rs1401635</td><td align="center" rowspan="1" colspan="1">C</td><td align="right" rowspan="1" colspan="1">ILI</td><td align="right" rowspan="1" colspan="1">0.055</td><td align="right" rowspan="1" colspan="1">0.316</td><td align="right" rowspan="1" colspan="1">0.862</td></tr><tr><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1">DSE</td><td align="right" rowspan="1" colspan="1">&#x02212;0.864</td><td align="right" rowspan="1" colspan="1">0.567</td><td align="right" rowspan="1" colspan="1">0.128</td></tr><tr><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1">Avg</td><td align="right" rowspan="1" colspan="1">&#x02212;0.405</td><td align="right" rowspan="1" colspan="1">0.325</td><td align="right" rowspan="1" colspan="1">0.213</td></tr><tr><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1">ILI-DSE</td><td align="right" rowspan="1" colspan="1">0.919</td><td align="right" rowspan="1" colspan="1">0.649</td><td align="right" rowspan="1" colspan="1">0.157</td></tr><tr><td align="left" colspan="8" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1"><italic>BDNF</italic></td><td align="left" rowspan="1" colspan="1">rs10767664</td><td align="center" rowspan="1" colspan="1">T</td><td align="right" rowspan="1" colspan="1">ILI</td><td align="right" rowspan="1" colspan="1">&#x02212;0.288</td><td align="right" rowspan="1" colspan="1">0.377</td><td align="right" rowspan="1" colspan="1">0.445</td></tr><tr><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1">DSE</td><td align="right" rowspan="1" colspan="1">&#x02212;0.504</td><td align="right" rowspan="1" colspan="1">0.657</td><td align="right" rowspan="1" colspan="1">0.443</td></tr><tr><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1">Avg</td><td align="right" rowspan="1" colspan="1">&#x02212;0.396</td><td align="right" rowspan="1" colspan="1">0.379</td><td align="right" rowspan="1" colspan="1">0.296</td></tr><tr><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1">ILI-DSE</td><td align="right" rowspan="1" colspan="1">0.216</td><td align="right" rowspan="1" colspan="1">0.758</td><td align="right" rowspan="1" colspan="1">0.776</td></tr><tr><td align="left" colspan="8" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1"><italic>MTIF3</italic></td><td align="left" rowspan="1" colspan="1">rs7988412</td><td align="center" rowspan="1" colspan="1">A</td><td align="right" rowspan="1" colspan="1">ILI</td><td align="right" rowspan="1" colspan="1">0.243</td><td align="right" rowspan="1" colspan="1">0.386</td><td align="right" rowspan="1" colspan="1">0.531</td></tr><tr><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1">DSE</td><td align="right" rowspan="1" colspan="1">&#x02212;0.916</td><td align="right" rowspan="1" colspan="1">0.663</td><td align="right" rowspan="1" colspan="1">0.167</td></tr><tr><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1">Avg</td><td align="right" rowspan="1" colspan="1">&#x02212;0.334</td><td align="right" rowspan="1" colspan="1">0.384</td><td align="right" rowspan="1" colspan="1">0.381</td></tr><tr><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1">ILI-DSE</td><td align="right" rowspan="1" colspan="1">1.158</td><td align="right" rowspan="1" colspan="1">0.768</td><td align="right" rowspan="1" colspan="1">0.132</td></tr><tr><td align="left" colspan="8" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1"><italic>SH2B1</italic></td><td align="left" rowspan="1" colspan="1">rs4788099</td><td align="center" rowspan="1" colspan="1">G</td><td align="right" rowspan="1" colspan="1">ILI</td><td align="right" rowspan="1" colspan="1">0.072</td><td align="right" rowspan="1" colspan="1">0.297</td><td align="right" rowspan="1" colspan="1">0.809</td></tr><tr><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1">DSE</td><td align="right" rowspan="1" colspan="1">&#x02212;0.480</td><td align="right" rowspan="1" colspan="1">0.521</td><td align="right" rowspan="1" colspan="1">0.358</td></tr><tr><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1">Avg</td><td align="right" rowspan="1" colspan="1">&#x02212;0.204</td><td align="right" rowspan="1" colspan="1">0.301</td><td align="right" rowspan="1" colspan="1">0.498</td></tr><tr><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1">ILI-DSE</td><td align="right" rowspan="1" colspan="1">0.552</td><td align="right" rowspan="1" colspan="1">0.600</td><td align="right" rowspan="1" colspan="1">0.358</td></tr><tr><td align="left" colspan="8" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1"><italic>FTO</italic></td><td align="left" rowspan="1" colspan="1">rs1421085</td><td align="center" rowspan="1" colspan="1">C</td><td align="right" rowspan="1" colspan="1">ILI</td><td align="right" rowspan="1" colspan="1">&#x02212;0.137</td><td align="right" rowspan="1" colspan="1">0.300</td><td align="right" rowspan="1" colspan="1">0.649</td></tr><tr><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1">DSE</td><td align="right" rowspan="1" colspan="1">1.173</td><td align="right" rowspan="1" colspan="1">0.553</td><td align="right" rowspan="1" colspan="1"><bold>0.034</bold></td></tr><tr><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1">Avg</td><td align="right" rowspan="1" colspan="1">0.518</td><td align="right" rowspan="1" colspan="1">0.315</td><td align="right" rowspan="1" colspan="1">0.100</td></tr><tr><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1">ILI-DSE</td><td align="right" rowspan="1" colspan="1">-1.310</td><td align="right" rowspan="1" colspan="1">0.629</td><td align="right" rowspan="1" colspan="1"><bold>0.037</bold></td></tr><tr><td align="left" colspan="8" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1"><italic>FTO</italic></td><td align="left" rowspan="1" colspan="1">rs3751812</td><td align="center" rowspan="1" colspan="1">A</td><td align="right" rowspan="1" colspan="1">ILI</td><td align="right" rowspan="1" colspan="1">-0.092</td><td align="right" rowspan="1" colspan="1">0.301</td><td align="right" rowspan="1" colspan="1">0.761</td></tr><tr><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1">DSE</td><td align="right" rowspan="1" colspan="1">1.559</td><td align="right" rowspan="1" colspan="1">0.551</td><td align="right" rowspan="1" colspan="1"><bold>0.005</bold></td></tr><tr><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1">Avg</td><td align="right" rowspan="1" colspan="1">0.734</td><td align="right" rowspan="1" colspan="1">0.314</td><td align="right" rowspan="1" colspan="1"><bold>0.020</bold></td></tr><tr><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1">ILI-DSE</td><td align="right" rowspan="1" colspan="1">&#x02212;1.651</td><td align="right" rowspan="1" colspan="1">0.628</td><td align="right" rowspan="1" colspan="1"><bold>0.009</bold></td></tr><tr><td align="left" colspan="8" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1"><italic>FTO</italic></td><td align="left" rowspan="1" colspan="1">rs9939609</td><td align="center" rowspan="1" colspan="1">A</td><td align="right" rowspan="1" colspan="1">ILI</td><td align="right" rowspan="1" colspan="1">0.054</td><td align="right" rowspan="1" colspan="1">0.289</td><td align="right" rowspan="1" colspan="1">0.851</td></tr><tr><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1">DSE</td><td align="right" rowspan="1" colspan="1">1.029</td><td align="right" rowspan="1" colspan="1">0.522</td><td align="right" rowspan="1" colspan="1"><bold>0.049</bold></td></tr><tr><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1">Avg</td><td align="right" rowspan="1" colspan="1">0.541</td><td align="right" rowspan="1" colspan="1">0.299</td><td align="right" rowspan="1" colspan="1">0.070</td></tr><tr><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1">ILI-DSE</td><td align="right" rowspan="1" colspan="1">&#x02212;0.975</td><td align="right" rowspan="1" colspan="1">0.596</td><td align="right" rowspan="1" colspan="1">0.102</td></tr><tr><td align="left" colspan="8" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1"><italic>FTO</italic></td><td align="left" rowspan="1" colspan="1">rs9922708</td><td align="center" rowspan="1" colspan="1">A</td><td align="right" rowspan="1" colspan="1">ILI</td><td align="right" rowspan="1" colspan="1">0.031</td><td align="right" rowspan="1" colspan="1">0.295</td><td align="right" rowspan="1" colspan="1">0.916</td></tr><tr><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1">DSE</td><td align="right" rowspan="1" colspan="1">1.382</td><td align="right" rowspan="1" colspan="1">0.551</td><td align="right" rowspan="1" colspan="1"><bold>0.012</bold></td></tr><tr><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1">Avg</td><td align="right" rowspan="1" colspan="1">0.707</td><td align="right" rowspan="1" colspan="1">0.312</td><td align="right" rowspan="1" colspan="1"><bold>0.023</bold></td></tr><tr><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1">ILI-DSE</td><td align="right" rowspan="1" colspan="1">&#x02212;1.351</td><td align="right" rowspan="1" colspan="1">0.625</td><td align="right" rowspan="1" colspan="1"><bold>0.031</bold></td></tr><tr><td align="left" colspan="8" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="center" rowspan="1" colspan="1">18</td><td align="center" rowspan="1" colspan="1"><italic>MC4R</italic></td><td align="left" rowspan="1" colspan="1">rs17782313</td><td align="center" rowspan="1" colspan="1">C</td><td align="right" rowspan="1" colspan="1">ILI</td><td align="right" rowspan="1" colspan="1">&#x02212;0.275</td><td align="right" rowspan="1" colspan="1">0.341</td><td align="right" rowspan="1" colspan="1">0.420</td></tr><tr><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1">DSE</td><td align="right" rowspan="1" colspan="1">0.252</td><td align="right" rowspan="1" colspan="1">0.619</td><td align="right" rowspan="1" colspan="1">0.685</td></tr><tr><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1">Avg</td><td align="right" rowspan="1" colspan="1">&#x02212;0.012</td><td align="right" rowspan="1" colspan="1">0.354</td><td align="right" rowspan="1" colspan="1">0.973</td></tr><tr><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1">ILI-DSE</td><td align="right" rowspan="1" colspan="1">&#x02212;0.527</td><td align="right" rowspan="1" colspan="1">0.707</td><td align="right" rowspan="1" colspan="1">0.456</td></tr><tr><td align="left" colspan="8" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="center" rowspan="1" colspan="1">19</td><td align="center" rowspan="1" colspan="1"><italic>QPCTL/GIPR</italic></td><td align="left" rowspan="1" colspan="1">rs11672660</td><td align="center" rowspan="1" colspan="1">A</td><td align="right" rowspan="1" colspan="1">ILI</td><td align="right" rowspan="1" colspan="1">0.131</td><td align="right" rowspan="1" colspan="1">0.373</td><td align="right" rowspan="1" colspan="1">0.726</td></tr><tr><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1">DSE</td><td align="right" rowspan="1" colspan="1">&#x02212;0.850</td><td align="right" rowspan="1" colspan="1">0.694</td><td align="right" rowspan="1" colspan="1">0.221</td></tr><tr><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1">Avg</td><td align="right" rowspan="1" colspan="1">&#x02212;0.359</td><td align="right" rowspan="1" colspan="1">0.394</td><td align="right" rowspan="1" colspan="1">0.362</td></tr><tr><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1">ILI-DSE</td><td align="right" rowspan="1" colspan="1">0.980</td><td align="right" rowspan="1" colspan="1">0.787</td><td align="right" rowspan="1" colspan="1">0.213</td></tr></tbody></table><table-wrap-foot><fn id="TFN10"><label>a</label><p id="P85">SNP effect within the intensive lifestyle intervention arm</p></fn><fn id="TFN11"><label>b</label><p id="P86">SNP effect within the diabetes support and education arm</p></fn><fn id="TFN12"><label>c</label><p id="P87">SNP effect averaged across treatment arms</p></fn><fn id="TFN13"><label>d</label><p id="P88">SNP &#x000d7; treatment arm interaction</p></fn></table-wrap-foot></table-wrap></floats-group></article>